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ABSTRACT  
 
With the development of supply chain, the collaborative supply chain management 
has increasing popular worldwide in recent years. There are many advanced method 
of achieving supply chain collaboration, such as VMI and CPFR, which focus on 
inventory management. In addition, it has been adopted by many industries such as 
manufacture (Dell) and retail (Wal-Mart).  
 
With the dramatically increasing of China drug market, more and more supply chain 
problems have appeared recent years. Due to redundant structure and complex 
network of pharmaceutical supply chain with high supply-related cost, it is necessary 
and urgent to integrating supply chain and developing collaborative inventory 
management (CIM). However, there are many problems block the implementation of 
CIM. This aims of this research is to find the current issues existing in hospital 
pharmacy inventory management as well as the barriers of implementing CIM in the 
whole pharmaceutical supply chain. Finally, combining with the capacity of 
pharmaceutical industry and the culture of China, the solution would be given at the 
end with some discussions.  
 
In this research, there are two methodology applied, interview and case study. The 
interview focus on understanding the current issue and barriers from different 
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members involved in hospital supply chain. It includes 11 interviewees from 4 aspects 
of the supply chain (manufacturer, wholesaler/distributor, hospital and government).  
In order to analyse specific problem of hospital pharmacy inventory management, one 
wholesaler/distributor company is selected from the previous interviewees with its 
upstream suppliers and upstream hospital. The customised modification is raised by 
using VMI and CPFR. In addition, combining with the outcome of interviews, the 
implementation of CIM in future China would be discussed at the end. 
 
 
 
Key words: Hospital supply chain, collaborative inventory management, VMI, CPFR 
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Chapter 1 
Introduction 
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1.1 Overview 
With the dramatically increasing of China drug market, more and more supply chain 
problems have appeared recent years. Due to redundant structure and complex 
network of pharmaceutical supply chain with high supply-related cost, it is necessary 
and urgent to integrating supply chain and developing collaborative inventory 
management. The existing research illustrates that the overall costs of this sector can 
be reduced by implementing collaborative inventory management (CIM) (Bhakoo et 
al.,2012). Moreover, the CIM could lessen the bullwhip effect.   
 
However, unlike other industries such as manufacture and retail where there have 
been experienced the supply chain management for a long history. The healthcare 
sector is behind other industries in practice of collaborative inventory management 
(McKone-sweet et al., 2005; Baltacioglu et al., 2007). 
 
In terms of the development of supply chain, the attention has changed from simple 
order making, purchasing and forecasting to collaborative management (Halley and 
Beaulieu, 2009). According to Bozarth and Handfield (2006) collaborative supply 
chain focuses on joint activities or establishing relationships with partners. In addition, 
Barratt(2004) indicates that the supply chain collaboration could integrate the external 
relationship between supply and demand as well as delivery, so that improving the 
performance of supply chain significantly.   
Dissertation of logistics and supply chain management 
11 
 
1.2 Problem statement 
In western countries, the pharmaceutical supply chain is constituted by general three 
echelons: manufacturer, wholesaler/distributor and retailer. In general, there are two 
channels of sale for manufacturer; one is directly to hospital, or selling through 
wholesaler/distributor. Moreover, the function of wholesaler/distributor primary is 
responsible for logistics providing distribution network. In terms of the profits of 
wholesaler/distributor, although it is relatively lower than other participants involved 
in supply chain, it still is accepted. Compared with China, there is a small amount 
drugs selling to hospital. For example in American, the drug sale and hospital are 
FRPSOHWHO\VHSDUDWHG7KHUHDUHDIHZFOLQLFDOGUXJVLQKRVSLWDO¶VLQYHQWRU\  
 
However, compared with western countries, the situation in China is totally different. 
The structure of supply chain is redundant and complex with large number 
intermediaries. In addition, most of wholesaler/distributor runs as sale agent 
undergoing the risk of accounts receivable from manufacture and hospital this will be 
explained detailed in 4.1.2.1. It is forbidden that pharmaceutical manufacturers sell 
their drug directly to hospital no matter the local company or foreign, the selling must 
via wholesaler/distributor. There are huge numbers of wholesaler/distributors with 
approximately 13,400 by the end of 2010 and the scale are small and scattered with 
little market share; this number in American is about 70. As a consequence, the 
development of market is extremely imbalance and with very low marginal income. 
Due to the long structure and with low level application of information sharing 
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between upstream and downstream of supply chain, the bullwhip effect is very serious, 
so that many backlogs inventory kept hospital and distribution company in China. 
Moreover most prescription drug control by hospital and the pharmaceutical industry 
is influenced by strong institutional and regulatory pressures (Shah, 2004). 
 
In 2011, the proposition of separating drug dispensing from medical put forward. That 
means the government of China supports the inventory of hospital could be managed 
by distributor instead of dominated by hospitals themselves. This proposition should 
bring many opportunities not only to the manufacturers, wholesalers but also to the 
patients. The wholesalers could be more initiative and motivated to dominate 
pharmaceutical industry. Regarding to manufacture, it is an improvement innovation 
of medicine and accuracy of forecasting. On the other side, the patients could enjoy a 
reasonable price of drug due to implementation of collaboration inventory 
management.  
 
However, it is very difficult to implement collaboration inventory management in 
Chinese pharmaceutical supply chain so that until today just few warehouse of 
hospital in Beijing managed by wholesaler/distributors. Therefore, there must be some 
barriers to implement collaboration inventory management. It is seen from Chinese 
big environment; First of all, the structure of pharmaceutical supply chain is more 
complex than other countries. There are less integrated distribution centres and 
advanced logistic infrastructure. Secondly, the information technology is increasing 
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widely application, but the information sharing and exchanging between the whole 
supply chain are still at a low level in China. On the microscopic aspects, 
pharmaceutical products are characterised by long developmental cycles that are 
distinctly different from medical devices. These long lead times have a significant 
impact on capacity planning and supply chain strategies, particularly inventory 
management (Shah, 2004). In addition, the operation of healthcare supply chain is 
different from the other businesses because it is extremely difficult for hospital to 
predict the consumption of patients (Jarrett, 1998; Scheller and Smeltzer, 2006). 
These factors lead to perennial problems such as stock-outs and drug expiry within 
pharmacy departments in hospitals. 
 
Therefore, it is necessary to introduce the strategy of collaborative inventory 
management in China hospital supply chain, and investigate the drivers and barriers 
of implementation. Finally the suggestions should be given combining with the 
current status of Chain.  
 
1.3 Objectives of the study 
The main objectives of the study are to investigate the current barriers and attitudes of 
hospital pharmacy inventory management from different roles (manufacturer, 
wholesaler/distributor, hospital and government) of pharmaceutical supply chain. The 
investigation is consist of 11 interviews which including 1 SFDA office, 3 
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manufactures, 5 distributors and 2 public hospitals. In addition, the analysis is also 
combined with one in-deep case study which involved three echelons of 
pharmaceutical supply chain for researching specific issues of hospital. In addition, 
the suggestions would be given combine with the theory of collaborative inventory 
management. Finally, the discussion of the implementing collaborative inventory 
management in China is an important part of this dissertation, as well. 
 
1.4 Research questions 
Based on core objective of this dissertation, two research questions are come up to 
satisfy the objective. 
Research Question 1 : what are the current issues of hospital pharmacy inventory 
management in China? 
Research Question 2 : what are the drivers and barriers to achieve collaborative 
inventory management in pharmaceutical supply chain? 
Research Question 3 :  How to implementing collaborative inventory management in 
China in the future? 
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1.5 Scope of study 
The study concentrates on the healthcare sector in Mainland China. For understanding 
comprehensively, 11 interviews involving a supply chain network of three 
pharmaceutical manufacturers, five wholesaler/distributors, two hospitals and one 
SFDA (Safe food and drug administration) officer were analysed. One of 
wholesaler/distributor (KY) with its downstream customer (301 hospital) as a case 
were also studied in-deep.  
 
1.6 Structure of work 
The structure of this dissertation is illustrated below:  
Chapter 2 (Literature Review) will introduce the current status of China 
pharmaceutical supply chain, including the market, structure and network of supply 
chain. Then the two common methods of collaborative supply chain management: 
VMI (Vendor-managed inventory) and CPFR (Collaborative planning, forecasting and 
replenishment) are explained in the next section. Finally, there are the discussions 
about the existing researches and empirical study in other industries and healthcare 
industry of these two concepts, respectively.  
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Chapter 3 (Research Methodology) will illustrate the two methodologies: interviews 
and case study. The question design and analysis method (Grounded theory) of 
interviews will be shown. With regard to case study, the primary and second data were 
collected, which mainly consist of qualitative data. In addition, the analysis method 
(Data Flow Diagram) was explained, finally.  
 
Chapter 4 (Data collection and analysis) will concentrate on analysis the attitudes as 
well as the barriers from four perspectives (manufacturers, wholesaler/distributors, 
hospitals and government). In addition, chapter 4 will analyse deeply the issues that 
existing in the operations of one of wholesaler/distributors with its partner.  
 
Chapter 5 (Findings and discussions) will show the results of the research, which 
including the initial and final improvements of 301 hospital pharmacy inventory 
management for KY with two data flow diagrams. Furthermore, the main drivers and 
barriers of implementing collaborative inventory management would be discussed in 
section 5.4. The discussions of CIM implementation in China in the future would be 
also included in this section.  
 
Chapter 6 (Conclusion) will summary this research and recommend the outcomes. 
Finally, the limitation of this dissertation would be presented.  
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1.7 Summary 
In this chapter, the overview of this dissertation has been mentioned including the 
problem statement, objectives, research questions and the scope of the study. This 
study will concentrate on Chinese pharmaceutical supply chain. In total, there are 11 
interviewees involved into this research and it could be divided into two parts: 
interview and in-deep case study. The main goal of this research is to provide insights 
on the true meaning of collaborative inventory management.  
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Chapter 2 
Literature 
review 
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2.1 Current status of pharmaceutical supply     
chain in China 
With development of economy, the position of Chinese drug market has been 
increasing gradually. The gross sales of drug in China took account for 12.7 per cent 
of world market in 2010, with increased from 0.88 per cent of 1978. The average 
increase rate of China pharmaceutical industry would still keep high level about 22-27 
per cent each year, compared with world average increase rate of 5-7 per cent in the 
next 10 years (SPDA).  
 
In addition, according to population census of China in 2010, the number of people 
over 60 years old was about 178 million, accounting for 13.26 per cent of gross 
population. Due to increasing of aging of population, China has been the driving force 
of the world pharmaceutical market according to the report published by IMS Health 
in 2010. In addition, Chain would be the biggest drug market in 2020 with huge 
potential and more foreign business would flood into (Yang and Liu 2010).  
 
 
Dissertation of logistics and supply chain management 
20 
 
 
Base on SPDA 
Figure2.1 Chinese drug market scale from2007 to 2010 (a hundred million RMB) 
 
In order to strengthen the competitiveness, the government of China has been invested 
heavily to promote rapid development of pharmaceutical industry in recent years. This 
figure shows that the proportion of investment of medical health accounting for 
central financial expenditure of Chinese government during three years from 2009 to 
2011.  
 
 
Figure2.2  Investment in healthcare sector in China from 2009 to 2011 
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2.1.1Hospital dominating market 
In chain, the three main terminal of sale are community healthcare institution, retail 
drugstore and public hospital pharmacy. Among them, hospital is the biggest retail 
approach. According to the statistics, the sales of hospital pharmacy are more than 70 
per cent of market share in 2012 (SPDA).  
 
 
Figure 2.3 Portion of pharmaceutical market share 
 
In addition, the vast majority of prescription medicines sell through public hospital in 
China (Liu and Cheng, 2000).Each year the centralized purchases of prescription drug 
are organized by government, but dominated by hospitals. Through the regional price 
bid, hospitals have right to select who could be the manufacturer for one kind of drug 
and what the quantity of order. Moreover, the pharmacies are managed by hospitals 
themselves with amount of labour and capital.  
 
However, separating drug dispensing from medical is a general law in many 
developed countries, such as America, Germany and Japan. It means that the doctor is 
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just responsible for making a prescription instead of sell drug. There is a few clinical 
drug in hospital inventory, which managed by pharmacist (Outlook weekly, 2007) 
 
Secondly, Chinese drug market is supply exceeding demand. The market is chaos 
with great number of small-scale manufacturers and wholesaler/distributors and 
located dispersedly. Moreover, approximately 80 per cent of pharmaceutical 
manufacture of China relies on imitation; it is often that one kind of drug produced by 
dozens or even hundreds of pharmaceutical factories, result in little differentiation 
between drugs and a mass of alternate (Yang Shu-jie, Liu Hao 2010). Therefore, 
public hospital of China has been absolute control power of market. 
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2.1.2 Structure of supply chain 
In China, the typical hospital supply model is six-hierarchy which shown as figure 4 
involving manufacturer --- national wholesaler/distributor --- regional 
wholesaler/distributor --- local wholesaler/distributor --- hospital --- patient.   
 
Figure 2.4 the structure of China pharmaceutical supply chain 
 
The characteristics of Chinese pharmaceutical supply chain are tediously long. Drugs 
firstly are distributed to different provinces from manufacture factories by national 
wholesaler/distributors and then purchased by regional wholesaler/distributors who 
responsible for dispatching the drug to required districts. The drugs then from local 
logistics centre flow into retail market and hospital. Alternatively, drugs for hospitals 
in metropolis such as Beijing, Shanghai would be distributed directly by local national 
wholesaler/distributors. However, generally hospitals cannot order from 
manufacturers directly, due to the undeveloped of third party logistics in China and 
particular regulation about the pharmaceutical cannot sell drug directly to hospital, it 
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must though the wholesaler/distributors in Chian (Liu and Cheng, 2000). Moreover, 
In China, the protectionism of district economy is very common (Hu et al.,2010); 
according to the GSP (good supply practice) it is nearly impossible to establish 
warehouse at other districts that outside the scope of business. Thus, it is blocked to 
national wholesaler/distributors to institute their own national-wide supply network. 
The drugs have to be distributed by regional wholesaler/distributors and transported 
WKURXJKORFDOORJLVWLFFRPSDQLHV¶QHWZRUN 
 
As consequences of tediously long of supply chain, the most serious problem caused 
is poor information communication exchange between upstream and downstream of 
supply chain. It can be seen from figure 4, there is nearly no data transfer between 
each participant. Each member of this traditional system is mutually independent, 
pursuing their own interests to maximize profits. With the expansion of the market, it 
is more difficult to control. The companies do not directly face the end of final 
consumption. The seriously lagging behind information will ultimately affect the 
competitiveness of distribution channels and product development (Andy and 
Mehmet.C, 2010). 
 
Another result of that is the price of drug has been driven up dramatically with cost 
adding in each stage (Sun et al.,2008). For example, first centralize public biding in 
December of 2002 within Sichuan provincial hospitals; most of the quotation prices 
were lower than the wholesale price by one-third. Some even less than fifth of the 
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wholesale price Huang Y. Z. (2001). However, the average gross margin is not high 
for Chinese wholesaler/distributor which is about 12.6 per cent mˈoreover, the average 
cost rate reached 12.5 per cent (Zhangˈ2008). It means there is about 1 per cent 
margin profit.  
 
Additionally, counterfeit drugs have opportunity to enter the market. SPDA (State 
Food and Drug Administration) is a department of Chinese governments, which 
responsible for monitor and trace the flow of drug and control the quality. However, 
due to supply chain excessive length, it is high difficulty to executive this job. &KLQD¶V
SFDA counted 188,122 cases of the distribution of unlicensed drugs and medical 
products in 2010. (SFDA)   
2.1.3 Pharmaceutical supply network 
Chinese pharmaceutical supply network is low integrated. As it shown in figure 5, the 
wholesaler/distributor network presents a shape of pyramid. This shape is better for 
market penetration, but it would cause poor information communicated˄Li et 
al.,2005˅.According to statistics from SFDA, by the end of 2010, there were more 
than 4678 pharmaceutical manufacturers in China, 13,461 pharmaceutical 
wholesaling and distribution companies (the number is 200 times that of the United 
States), 261,996 drug retail stores (the number is five times that of the United States) 
(SFDA).  
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Figure 2.5 Pyramid-shaped Network 
 
However, the vast majority of distributors are very small-scale in China; only 
approximately 400 wholesaler/distributors have more than 50 million RMB in annual 
sales. In 2012, the three largest enterprise sales accounted for only about 20% of the 
pharmaceutical market share. However, in United States, there were about 70 
pharmaceutical wholesale enterprises, and the sales of top three commercial 
pharmaceutical companies accounted for more than 90% of the share of the national 
drug market. The comparison between and Chain and America has been shown on 
table 1. China's pharmaceutical supply network is low integrated with lack of supply 
chain management and, leading to expense ratio of distribution and logistics is more 
than four times of international advanced level (Zhi Yan consulting company 2012.)  
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Base on Zhi Yan consulting company 2012 
Table 2.1 comparison of China and the United States 
 
 
 
Figure 2.6 the supply network of China pharmaceutical industry 
 
Another characteristic of China pharmaceutical supply networks is over complex and 
chaos. In general for one large-scale manufacturer, it has more than 50 direct 
wholesaler/distributors and 150-300 indirect wholesaler/distributors. Local 
protectionism in China is very normal. It is nearly impossible to establish warehouse 
at other districts that outside the scope of business. Therefore, currently, only two 
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strength enterprises Sinopharm and Jointown have their own national distribution 
networks, and other companies merely have local distribution network (Ma and 
Huang, 2010). 
 
Numerous participants and overlapping supply network could cause conflict of 
channel, which refers to companies established two or more channels in the same 
market. Because pricings of drug are different in different provinces, in order to win 
customer, some distributing companies purchase the drug with lower sale price that 
sold in other province, and then sell them to local retailers with the price lower than 
the rivals, thereby obtaining more profits (Hu chun, (2007). This kind of behaviours 
has seriously disrupted the market order and reducing loyalty of manufacturers. 
 
2.1.4 Information sharing 
In China, 95 per cent of pharmaceutical wholesaler/distributors have IT systems, but 
is largely due to the rigid rules of the GSP (Good Supply Practice). GSP is a 
standardized management system referring to planned purchase, inspection, storage, 
sales and after-sales service and other sectors, to ensure quality of drug during 
circulation (Ma and Huang, 2010). However, only less than half of the pharmaceutical 
enterprises operate management by information systems (Hu et al., 2010). Moreover 
much software just could satisfy the requirements of transportation planning and 
manufacturing resource planning stage, lack of the awareness of implementation of 
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the enterprise resource planning (ERP). With regard to information open, there are 
88.7 per cent of enterprises have internal LAN, while only 11.7 per cent of companies 
published the information on the website Kufang (2005). 
 
It has been applied barcode technology for 10 years in China, but the rate of 
utilization mere 58.8 per cent in pharmaceutical industry, which far below it of food 
and daily necessities(Lang, 2009). The lower barcode usage would inevitably lead to 
the low efficient inventory management and high error rate. Moreover, there is on 
uniform drug code and coding standard for pharmaceutical industry. Different parts of 
the supply chain develop their own logistics encoding, it results in that codes may 
only be used in their internal system, not compatible with each other. Thus, 
information sharing between upstream and downstream in pharmaceutical supply 
chain is still not achieved. The inefficient communication would inevitably hinder the 
development of supply chain. 
 
2.1.5 Third party logistic  
3PL (third party logistic) could solve this problem. 3PL (Third party logistic) means 
that the external logistic organization acts as the connection between company and 
client to provide logistic services. With the increased market competitions and 
customer requirements, more and more companies outsource their logistic activities to 
third party logistic service providers in order to pay more attentions on their core 
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activities (Vaidyanathan, 2005) and to achieve greater competitiveness (Welson, 
1996).  
 
2.2 Healthcare supply chain 
2.2.1 Supply chain structure 
With the development of public healthcare services in many countries all over the 
world, the costs of healthcare are increasing rapidly. The healthcare issues like 
medical errors, safety and growing medical costs are drawing more and more 
attentions (Stock et al., 2007; Gowen et al.,2008). One important aspect of healthcare 
is its supply. As Grossman (2000) said, in a typical hospital, 38 percent of expenditure 
on goods is spend on moving and handling supplies, and this is significant compared 
with less than 10 percent for most industries. Nachtmann and Pohl (2009) give a more 
UHFHQWILJXUHDERXWWKHSURSRUWLRQRIKHDOWKFDUHSURYLGHU¶VFRVWRQVXSSO\FKDLQ7KH\
pointed out that 31 percent of the averaJH KHDOWKFDUH VHUYLFHV SURYLGHU¶V DQQXDO
operating expenditure is on the cost of supply chain activities, including infrastructure, 
assets, information, procurement, delivery, storage, return and healthcare related 
disposal of products. 
Therefore, managing the healthcare supply chain in an efficient way is significant to 
the performance of service provider on its cost and quality. 
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Figure 2.7 Typical healthcare supply chain structure  
 
As it is shown in figure 2.7, the typical healthcare supply chain structure in most 
developed countries consists of 4 parts: producers, purchasers, providers and patients 
(Burns, 2002). Moreover, these components could be divided into two groups: the 
internal chain, like hospital storage and patient, and the external chain, like 
manufacturers and distributors (Schneller and Smeltzer, 2006).   
 
Producers produce drugs, medical devices, and medical or surgical supplies in the 
beginning of the supply chain. In general, producers operate significant number of 
product pipelines to maintain their productivities.  
 
Purchasers, which typically consist of GPOs (group purchasing organizations) and 
distributors, are responsible for the trades and shipping of products from producers to 
providers. Shah(2004) states that approximately 80 per cent of healthcare demands in 
UK are transmitted through intermediaries of purchasers and three dominant 
purchasers account for approximately all the demand in UK healthcare market. It shall 
be noted that the purchasers in the supply chain tend to be less and large (Shah, 2004). 
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The Australian healthcare supply chain also has the similar composition: 35 
pharmaceutical manufacturers (Medicines Australia, 2008) and 1250 
hospitals(Australian Government: Department of Health and Ageing, 2007), but only 
5 distributors/wholesalers(More and McGrath,2002). In addition, providers could also 
trade with producers directly without the patricianly of purchasers. If the demands are 
large, hospitals and retailors would request shipments from producers distribution 
centre directly in the consideration of efficiency and flexibility (Mustaffa and Potter, 
2009).  
 
At the final stage of the healthcare supply chain, providers such as hospitals, 
pharmacies and clinics would use the medical products to provide healthcare services 
to patients.  
 
As Singh et al.(2006) says that there are three types of flows in the process of supply 
chain management: physical product flow, data flow, and financial flow. The physical 
product flow manages the healthcare goods and services to meet the demands of 
patients. Data and financial flows are used to present the efficiency of product flow 
and the operating performance in the healthcare supply chain design (Kowalski, 
2009). 
According to Shah (2004), some typical features of the healthcare supply chain that 
reflects the performance could be seen. He points out that it would cost 1000 hours to 
8000 hours for a product to get through the entire supply chain. Moreover, he says 
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that the inventory levels are typically equal to 30 percent to 90 percent of annual 
demand in quantity and this would occupy 4 to 24 weeks stock time of finished goods. 
 
Related to the implementation of supply chain management in pharmaceutical 
industry, a number of issues would be specified.  
 
2.2.2 Characteristics of medicine 
2.2.2.1 Drug life cycle 
 Like most market products, pharmaceutical products also have their own life cycle. 
Three stages of its life cycle are tightly associated with the management of 
pharmaceutical supply chain. Firstly, due to the special characteristics of drug, the 
lead time of a new drug is long. Besides, the research and development for a new drug 
would cause large cost. Dan (2004) reveals that the development for a new drug 
would typically cost 800 million dollars and 14 years. Secondly, after the product has 
been approved to spread into market, it would meet its period of patent protection. 
Because the low market competition, pharmaceutical products are spread rapidly to 
occupy as large market as possible. Due to the high cost on the research and 
development of drug, Drug Company would make best effort to recoup its cost (Dan, 
2004). However, this golden age seem not to bring significant improvement on the 
supply chain. On the one hand, this competition-free period is shorten, typically from 
5 to 1 years (Shah , 2004). On the other hand, when pharmaceutical company mainly 
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focuses on the large profit, the sense of improving the management of supply chain is 
low. Finally, the patent protection expired. Large number of alternative products or 
generics would make the market more competitive (Lauer, 2004). This would produce 
great pressure on the entire supply chain. 
2.2.2.2 Business education   
In a supply chain, physicians generally master the of decision-make rights of 
procurement. However, their sense of supply chain management seems to be low 
(Scheller and Smeltzer, 2006) This would hinder the improvement of supply chain.  
 
2.2.2.3 Forecasting  
Forecast is a key factor in the healthcare supply chain management. But due the 
special characteristics of pharmaceutical industry, it is difficult to be well operated. 
According to (Kathleen et al., 2005), the difficulties exist in forecasting frequency, 
primary diagnoses for patient and the related pharmaceutical product demand. 
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2.3 Collaborative inventory management 
(CIM) 
Simatupang and Sridharan (2002) say that supply chain collaboration is more than one 
independent enterprise working together to plan and undertake the operation of supply 
chain with greater success than before acting alone. It is different from supply chain 
integration, which indicates interaction and assimilation among members rather than 
focus on physical combination and structure in a supply chain (Ryu, 2006). There are 
many routine functions of supply chain involved in collaboration, such as distribution, 
inventory management. 
 
The collaboration began with mainly focused on information sharing among supply 
chain participants in order to improve an efficient supply chain (Ryu, 2006).  
Currently, more advanced technology and concepts are achieving instead of only 
sharing information. Moreover, these wealth concepts have been discussed worldwide, 
such as vendor managed inventory (VMI) and Collaborative planning, forecasting and 
replenishment (CPFR) and collaborative logistics management. It has been generally 
accepted by many industries, because of the unbroken, synchronized, quick 
responsiveness and lower inventory/logistics costs (Holweg et al., 2005 ).  
 
The most important advantage of collaborative supply chain management is reduce 
cost, accelerate operation and improving quality for both parties involved, through 
building cross-team, in terms of initially inventory and overall management 
Dissertation of logistics and supply chain management 
36 
 
(Mehrjerdi, 2009). In addition, Ryu(2006) simulated that the more advanced 
collaboration mechanisms such as VMI and CPFR gain greater profit than less ones.  
 
2.3.1 Vendor-managed inventory (VMI) 
2.3.1.1 Introduction  
According to Cetinkaya and Lee (2000), VMI was established by Wal-Mart firstly, 
which is a type of collaborative supply chain. It can be seen from the name, 
vendor-managed inventory, the vendor takes full management responsibilities of 
inventory that belongs to retaLOHU¶VZDUHKRXVHRyu (2006) indicates that This kind of 
transfer not only benefits retailers focus on their core business and no more burden 
inventory management, the suppliers could replenish and delivery the orders more 
flexible, as well. Furthermore, the information sharing has been deeper through VMI.  
 
The original goal of VMI is to improve the performance of the whole supply chain 
(Simchi-Levi et al., 2000). Ryu (2006) points out that there is still a limitation because 
of the nature of the business, which could be a conflict of the relationship between 
suppliers and retailers in terms of the weight of the profits. To same extent, the 
suppliers have a saving from inventory reduce in their warehouse, while the low stock 
level might cause the loss of sales and be counterproductive.  
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However, with regard to inventory holding cost, the VMI is definitely an effective 
model of inventory management. Traditionally, in order to lessen the stock outs, some 
safety stock would be kept. It general has negative effect on inventory holding cost. 
Compared with the conventional management, the VMI has been overcome the 
limitation. In current system, the inventory holding costs of retailers are eliminated 
and the service flexibility is increased by more efficiency arrangement of the 
production planning, delivery, and replenishment.  
 
2.3.1.2 Existing researches of VMI 
In terms of the existing researches, the first one should be mentioned is the 
performance of VMI on reduction of inventory level and cost. Yao (2002) uses a VMI 
model to test the effectiveness of VMI. Focusing on the important aspect of 
VMI--information sharing, he points out that the manufacturer would save more 
inventory carrying cost than retailer since the ratio of inventory carrying spending or 
the ratio of replenishment lead time becomes higher. Moreover, by comparing VMI 
with other two supply chain coordinating techniques, VMI shows the greatest 
performance on reducing inventory level due to the relative high replenishment 
frequency. Besides, by using VMI, the safety stock ad cycle inventory could also be 
reduced to some extent. 
 
In the research of Disney and Towell(2003), the VMI effectiveness of reducing 
bullwhip effect is studied. Lee et al.(1997) describes bullwhip effect as larger 
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fluctuations FDXVHGE\EX\HU¶VRUGHUV WR VXSSOLHU WKDQVDOHVYDULDELOLW\ WREX\HUV ,Q
other words, the distortion in upstream is amplified. Consequently, the order variance 
results in significant cost in the system because of uncertainty of demand in each 
echelon when moving upward the supply chain. It is noted that this kind of 
inefficiency is caused by the deficiency in communication in the supply chain 
structure (Chen, et al. 2000.). As a number of studies indicate, the demand visibility in 
supply chain would be efficient in coping with such a costly effect (Forrester, 1958). 
Therefore, a well-established information sharing mechanism would be effective in 
solving the bullwhip effect. Disney and Towell(2003) researches the performance of 
VMI on bullwhip effect of a supply chain by measuring the comparison between a 
VMI supply chain and a traditional supply chain. The traditional supply chain is set as 
a benchmark to measure the improvement that provide by VMI. By using difference 
equations with parameters from researches of John et al. (1994), Disney et al. (1997) 
Naim and Towill (1995), and Dsiney(2001), the VMI supply chain and the traditional 
supply chain are simulated as mathematical model. In this way, the VMI performance 
is measured qualitatively and quantitatively.  
 
Consequently, VMI shows great capabilities in resistance with bullwhip effect:  
firstly, large reduction of bullwhip effect at responding to instable change of demand 
caused by price variations or commercial promotions; secondly, better performance in 
terms of the inventory recovery; lastly, less order rate variance due to random 
customer demand under practical retail sales pattern. 
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Unlike most researches that focusing on the performances of implementation of VMI, 
the research of Dong et al. (2007) mainly concentrates on the environmental 
determinants of the adoption of VMI. He points out that the effectiveness of adopting 
VMI is not generally positive despite a number of researchers present the remarkable 
results of adoption of VMI. This concurs with Cook (1998) that the mix influences of 
VMI cause the abandonments by a number of companies. Therefore, to find out these 
mixed environmental determinants is crucial for the decision of firm on the adoption 
of VMI. He supposes five environmental determinants that might be related to the 
adoption of VMI by buyers, and then survey the purchasing managers of great VMI 
adopted industries such as Industrial Machinery and Equipment. As a result, three 
K\SRWKHVHV DUH VXSSRUWHG WKH FRPSHWLWLYHQHVV RI WKH VXSSOLHU¶V PDUNHW
buyer-supplier cooperation, and operational uncertainty for the buyer. The first two 
factors are closely connected to the adoption of VMI while operational uncertainty for 
the buyer seems to have relative low connection. 
 
2.3.1.3 VMI in healthcare 
Not like the widely use of VMI systems in other industries such as manufacture and 
retail (Achabal et al., 2000; Vigtil, 2007), the application of VMI system in 
pharmaceuticals industry is still at its stage of development. This results in the relative 
less number of empirical studies on implementations of VIM systems on healthcare 
supply chain. However, with the features of sharing risks and reducing inventory costs 
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of VIM becoming more and more prominent, a number of recent studies highlight the 
applications of VIM technologies on healthcare field. 
 
Haavik (2000) introduces a VMI software which could help hospitals that based on 
IDS (integrated Delivery Systems) to reduce the supply chain management costs. The 
VMI software could derive forecasting data based on the historical information of an 
item by calculating the standard deviation of the demand and the delivery time, 
seasonal factors and other related factors. Moreover, combining with the demand 
information, the software calculate the optimum order, stock level, lead time, and then 
produce an order. In this way, the inventory and demand information collected at the 
hospital could be converted into recommendations about amount of orders and 
delivery schedule for the distributor. This brings a number of benefits: for an 
average-level hospital with total materials purchased value of 16.7 million dollars, its 
on-hand inventory requirements could be reduced by 69 per cent which means more 
free capital and less inventory maintaining fee; the approximate expenses for carrying 
30 per cent of inventory could be saved; the purchase-order processing costs 0.631 
million dollars could be eliminated because of the order-generating automation.  
 
What Kim (2005) studying also illustrates the advantages of VMI in healthcare supply 
chain. He presents the function of VIM in enhancing the efficiency of healthcare 
supply chain in South Korea. He states a concept of EHCP (Efficient Healthcare 
Consumer Response) which is an industry-wide effort aimed at making an efficient 
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healthcare supply chain. In other words, the purpose of EHCP is to reduce the cost 
and enhance the effectiveness in the healthcare supply chain. To meet this 
requirement, VMI technology is implemented for distributor to manage the warehouse 
of hospital. As a result, the effect in advancing the healthcare supply chain is 
pronounced. Firstly, combining with electronic information interchange technology, 
the information integration in this supply chain management is optimized. Moreover, 
the workload of staffs in hospital could be reduced so that they could focus on their 
own specialized work. Finally, the most significant improvement is that the total 
inventory is reduced by more than 30 per cent.  
 
Compared with the relative simple analysis of Kim (2005), Danese (2006) develops 
the research of VMI to an extended model by reVHDUFKLQJDFDVHRIRQHRIWKHZRUOG¶V
leading research-based healthcare providers GlaxoSmithKline. He illustrates that the 
application of VMI in supply chain could be extended from the simple chain level to 
the network level. For both upstream and downstream of the vertical direction of the 
network, VMI would be used to realize the information circulation and exchange 
among players in the supply chain. This could reduce the bullwhip effect, and then 
reduce the inventory level while keeping a relative high service level (Waller et al., 
1999; Disney and Towill, 2002). Moreover, the data exchange in the horizon direction, 
which indicates the partners in the same echelon, is also useful. This enhances the 
responsiveness to the demands of customer and the integration level of the supply 
chain network. In addition, the issue of information sharing across the network 
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enables each participant to measure performance of other members, and then to build 
of trust in the long term. However, Barratt (2004) states that it seems to be hard to 
implement collaboration in practice because of the lack of trust between trading 
partners. What (Augulo et al., 2004) points out would also support the similar issue 
with Barratt (2004). He considers that he limitation of trust between the hospitals and 
the manufacturers would block any form of supply chain management collaboration. 
Moreover, he presents trust as the most crucial factor for successful implementation 
of VMI. 
 
As a recent study on the collaborative management of inventory, Ryu (2006) reveals 
several contingent factors which could be the key issues that would affect the 
implementation of VMI. The study is based on the supply chain structure of a number 
of Australian pharmaceutical organizations: three manufacturers, two distributors, and 
five hospitals. Among these organizations, one manufacturer and both of the two 
distributors use VMI systems to manage their healthcare supply chain. For this 
manufacturer, the implementation of VMI is based on the direct connection to the 
hospital and the characteristics of their providing products. Fisher (1997) says that 
these products have features of stable demand, relative long life cycle, and low 
stock-out rate. In addition, Ryu(2006) points out WKDW WKH ³ZDUG ER[´ V\VWHP LV
operated in the investigated hospitals to implement the collaborative supply chain 
management. There are three models of this system, and with the model level 
increasing, the distributor would have higher capability to manage the providing and 
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demand in the hospital so that to reduce the inventory and release workloads of the 
hospital staffs. By collecting analysing data from echelon level to chain level, finally 
he divides the finding to three specific perspectives from manufacturer, distributor, 
and hospital, separately, and then he points out five factors that could influence VMI 
collaborative management: product characteristics, spatial complexity, and degree of 
goal congruence, regulatory environment, and physical characteristics. This is 
coincides with the study of Danese (2007) about the collaborative management. 
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2.3.2 Collaborative Planning Forecast 
Replenishment (CPFR) 
 
2.3.2.1 Introduction  
CPFR (Collaborative Planning Forecast Replenishment) is another method of 
collaborative inventory management, which was developed by a consumer goods 
manufacturer---Warner-Lambert, and Wal-Mart in 1996 (Simchi-Levi et al., 2000). 
 
Sherman(1998) defines CPFR as an advanced supply chain management model that 
apply a holistic mechanism to all the partners in supply chain and to integrate the 
business activities in the supply chain by effectively sharing and exchanging 
information based on cooperation. Boone and Ganeshan (2000) claim that, Compared 
with VMI, CPFR seems to be more advanced in collaboration because it focus on 
joint forecasting and planning rather than independent; moreover, all partners are 
involved in common business with positive behaviours.  
 
With the funding support of Wal-Mart, IBM, SAP, and Manugistics, CPFR is 
developed by Benchmarking Partners in 1996 (Fliedner, 2003). At the beginning of its 
development, researchers study it on collaborative forecasting. This mainly focuses on 
the early demand data exchange in the supply chain. In the medium-term of its 
development, the initial collaborative forecasting is advanced to CFAR (Collaborative 
Forecasting and Replenishment) (Ryu, 2006). It refers to forecast and replenish jointly 
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based on coordinative collaboration. Finally, to strengthen the collaborative 
management efficiently, the function of collaborative production and purchasing 
planning is developed in CPFR. 
 
According to Kamalapurkar(2011), CPFR is developed as the latest coordination 
mechanism on collaborative supply chain management. Comparing with the earlier 
arrangements of collaborative supply chain management, such as VMI, CPFR acts on 
not only replenishment, but also on demand forecasting and production planning. This 
concurs with the study of Boone and Ganeshan (2000). They state that the typical 
VMI gives little chance for customer to participate in decision-make activities; as a 
result, supplier could not make exact corresponding of demand forecasting, 
production planning, and replenishment. However, CPFR provides a collaborative and 
joint environment for both customer and vendor to implement such advanced supply 
chain management.  
 
2.3.2.2 Existing researches of CPFR 
Collaborative forecasting is one of the most important aspects of CPFR. There is a 
number of studies focus on this function of CPFR. For instant, Aviv(2002) uses a 
two-stage supply chain model to simulate the collaborative forecasting of CPFR. In 
the study, the two-stage model presents the retailer and the supplier, moreover, with a 
single trading product in the supply chain. To achieve a systematic analysis of the 
supply chain performance with collaborative forecasting, three supply chain settings 
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about the forecasting and replenishment policy are set: traditional supply chain setting, 
local forecasting setting, and collaborative forecasting setting. The first one does not 
have any forecasting mechanism in its supply chain and is set as a benchmark. The 
local forecasting model set a semi-collaborative collaboration model between the 
customer and the supplier: the partners in supply chain could share all static data such 
as characteristic information about their own forecasting process, but no specific 
information about local inventory and their own demand forecasts. In the 
collaborative forecasting setting, the only difference with local forecasting is that all 
partners in the supply chain jointly manage one common forecast process, and then 
apply it into replenishment policy. By converting the supply chain model and process 
into mathematical model, the benefits are derived in numerical. As a result, compared 
with the benchmark, the local forecasting model and the collaborative forecasting 
model decrease the supply chain expenditure by 11.1% and 19.43% on average, 
separately. This significant CPFR effectiveness concurs with the study of Boone and 
Ganeshan (2000). In addition, they point out that CPFR could reduce 6.5% inventory 
without decreasing of service level.  
 
Like the two studies mentioned above, most CPFR researches mainly focus on 
identify the advantages such as reducing inventory or cost in the supply chain. In 
addition, the execution and operation of CPFR defined by VICS (1999) are set as 
default in these studies (Barratt and Oliveira, 2001; Crum and Palmatier, 2004). 
However, Seifert (2003) points out that there are a number of different CPFR patterns 
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in practical. This is coincident with the study of Larsen et al. (2003).  It mainly 
focuses on these variants of CPFR and the contingent factors that result in such a 
variety. As the source of analysis, it is noted that the collected data is gathered by 
interviewing form seven companies of different industries. By within-case and 
cross-case analysis, the author points out that the depth of collaboration and the 
number of interacting units are two variables to indicate the CPFR collaboration. The 
depth of collaboration is classified to three levels: communication, limited 
collaboration, and full collaboration. It is noted that increasing depth of collaboration 
means more units are interacted between companies. Moreover, the contingent factors 
for the depth of collaboration and the number of interacting units are given: for the 
depth of collaboration, CPFR goals, product/market characteristics, and supply 
QHWZRUN¶V SK\VLFDO VWUXFWXUH ZRXOG FRQWULEXWH IRU WKH QXPEHU RI LQWHUDFWLQJ XQLWV
VXSSO\QHWZRUN¶VSK\VLFDOVWUXFWXUH&3)5GHYHORSPHQWVWDJHZRXOGFRQWULEXWH  
 
2.3.2.3 CPFR in healthcare 
Like the studies on VMI, the researches addressing the issues of CPFR mainly focus 
industries of manufacture and retailer. However, with the increasing complexity of 
pharmaceutical industry and recognition of advantages of collaborative supply chain 
management, a number of researches highlight the empirical implementation and 
issues of CPFR. 
 
In the study of  Danese(2004), a supply chain network managed by CPFR is 
Dissertation of logistics and supply chain management 
48 
 
emphasised. The CPFR is first adopted by the central multinational company in this 
supply network in 1998, and now widely used on the supply chain management by 
most partners in the supply network, such as manufacturers, sales companies, and 
distribution centres. As the authors state, the implementation of CPFR is first set by a 
specific front-end agreement which is made by managers from all the partners in the 
supply chain network. This agreement specifies the running process and the allocation 
of tasks of planning, forecasting, and replenishment. This agreement would also lead 
the definition of joint business plan, which indicate all the details for each product 
plan for next year, like cost-service target, lead time, safety stock, etc. Moreover, the 
CPFR forecasting process is also implemented jointly. The sales histories from 
distribution centres and the qualitative data from sales companies such as market 
trends, government policies, would be jointly in forecasting. In details, each sales 
company is responsible for the sales forecasts for its served country and could 
exchange qualitative information with other sales companies to enhance forecasts. 
This idea partly concurs with the study of Danese(2006) about the extended 
collaborative supply chain management in the supply network. Furthermore, the 
forecasting data would be correcting sent to manufacturers and suppliers. The 
managers at these units would check the forecasting data. If any objection exists, they 
FRXOG GLVFXVV LW ZLWK VDOHV FRPSDQLHV LQ WKH ³FRQVHQVXV PHHWLQJ´  $IWHU WKH ILQDO
forecasting data is confirmed, central software would be used to produce the plans of 
order forecast. By jointly considering the distribution centre inventory level and the 
forecasting plans, manufacturer would accomplish the replenishment of distribution 
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centre by using VMI.  
 
The study of Danese(2004) presents an entire process of the implementation of CPFR. 
The business plan of the supply chain is jointly defined by all partners in the supply 
chain network. Moreover, the sales forecasting is jointly deduced by sales 
organizations in the same echelon combined with the feedbacks from manufacturers 
and suppliers. In this way, the supply chain network is advanced not only in vertical, 
but also the horizontal direction. Finally, it is worth noting that the process in this 
CPFR system is accomplished by using VMI.  
 
 
 
 
 
 
 
 
 
Dissertation of logistics and supply chain management 
50 
 
 
2.4 Research questions 
According to the literature review, there is a gap to be filled. Firstly, although a 
number researches about VMI and CPFR have been adopted by other industries. The 
application in healthcare sector is still not very popular. In addition, there is a few 
empirical study combine these two concept together to solve problem in healthcare 
inventory management. Through the comparison of hospital supply chain between 
western country and China, there is a long way to go for China in the supply chain 
collaboration, in terms of information technology, logistic capacity, reasonable policy 
etc. 
 
In order to fill this gap, three research questions has been shown as follow:  
 
Research Question 1 : what are the current issues of hospital pharmacy inventory 
management in China? 
Research Question 2 : what are the drivers and barriers to achieve collaborative 
inventory management in pharmaceutical supply chain? 
Research Question 3 :  How to implementing collaborative inventory management in 
China in the future? 
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Chapter 3 
Research 
Methodology  
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3.1 Introduction 
According to Literature review of this dissertation, it explored the gap between 
Chinese contemporary development of pharmaceutical supply chain and the world 
advanced pharmaceutical supply level. In order to fill the gap and find the barriers 
that blocking the implementation of collaborative inventory management in China, 
the research is designed into two parts. The first part is about the research of holistic 
attitudes to CIM, which involved 11 interviewees from four different members of 
supply chain: 1 officer from government, 3 pharmaceutical manufacturers, 5 
wholesaler/distributors and 2 hospitals. This research is focus on the hospital supply 
chain, and the wholesaler/distributor has the direct relationship with hospital. 
Therefore, the wholesaler/distributor accounts for the largest number of interviews. 
However, the operation of manufacturers would also affect the inventory level of 
hospital pharmacy. During interview, it was found that there was one 
wholesaler/distributor going to run the business of pharmacy trusteeship. To be more 
in-deep research, the case study was following the interviews, in order to collect more 
qualitative and quantitative data to analyse.  
In this chapter, interviews and case study were adopted by this research with 
separated explanations in detail. The reasons of why these two research strategies and 
whether suitable or not would be explained as well in this follow content. Moreover, 
the detailed principles and method of design and analysis of this research studies were 
presented as well. The most important part of this chapter was the implementation of 
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these methods. Finally, the weakness and limitation of these methods would be 
illustrated. 
3.2 Interviews 
Burnard (1991) said that interview is one qualitative research method. The interview 
is the one of the most efficient way of data gathering (Yin, 1994). The method could 
be divided into unstructured interview and semi-structured interviews (Burnard, 1991). 
According to Steinar (1996), it is necessary to identify the subject or main topics 
before execution, but the structure of the interview is flexible. Moreover, the 
interviewers may add new questions depending on the situation at that time during the 
interview.  
3.2.1 Questions Design  
Semi-structured interviews were selected by author and the scope involved 11 main 
participants in supply chain, which were one SFDA officer, three manufacturers, five 
wholesaler/distributors and two public hospitals, respectively. To be representative, 
WKH WKUHH PDQXIDFWXUHUV FRQVLVW RI RQH &KLQD¶V VWDWH-owned manufacturers, two 
foreign companies. In terms of wholesaler/distribuWRUV IRXU &KLQD¶V VWDWH-owned 
companies and one private firm taking participate into this research. In the meanwhile, 
two public hospitals involved as well. In total, the interviewees are 10 operation 
managers and 1 government officer.  
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In terms of the topic of interviews, it must be around the purpose of this dissertation 
and answer the two research questions. Research question 1: what are the current 
issues of hospital pharmacy inventory management in China? Research question 2: 
what are the drivers and barriers to achieve collaborative inventory management in 
China? In order to answer the questions and gain a holistic and comprehensive 
understanding, the purpose of the interviews is to explore the issues of current 
hospital inventory management and understand the attitudes to implementing 
collaborative inventory management from different perspectives. Most important is to 
collect the drivers and barriers of CIM on hospital pharmacy.  
 
Form the literature reviews, it could be clear that two main decisive factors involved 
in inventory management which are information technology and logistics capacity. 
Hence, the interview questions are divided into three parts: Implementation of IT, 
Logistics level and Inventory management. In addition, according to diverse 
participants from three parts of supply chain, there are different focuses. First of all 
for the distribution part, the most important functions are storage and logistics, but 
without the support of advanced information system these functions could not be 
achieved. Hence, the questions involve current models of inventory management; the 
attitudes to implementation of collaborative inventory management; the biggest 
barriers and divers faced; information sharing and exchange with upstream and 
downstream partners; logistics level and cost, etc. As the downstream and upstream 
for distributor, the information flow unblocked and inaccuracy are the most important 
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element for demand forecasting, innovation of product and production. Thus, the 
questions more focus on IT and communication within the supply chain. Meanwhile, 
the attitudes to Joint-inventory management, the drivers and barriers are included as 
well. With regard to officer, the questions are more holistic which designed for 
policies guiding to development of pharmaceutical supply chain with focus on 
integration of structure, changing of market domination and development of medicine 
logistics. Finally, each participant was asked for one open-ended question about the 
most processing issues in practical pharmaceutical supply chain.  
 
 
              Table 3.1 the themes and number of questions of Interview  
 
The designed questions could allow interviewees to focus on the themes and could 
answer freely. Table 3.1 illustrates the topic and the number of questions. All answers 
are given by interviewees by their experience and depending on their knowledge of 
the companies.  
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3.2.2 Grounded theory  
 
Source: base on Glaser and Strauss (1967)  
Table 3.2 WKHVWHSVRI³*URXQGHGWKHRU\´ 
 
 
Although the process of interviews is straightforward enough, it is difficult to analyse 
DQGLQWHUSUHWWKHFRPSOHWHGWUDQVFULSWV%XUQDUG³*URXQGHGWKHRU\´DUHDGRSW
by this dissertation and extensively used to analyse semi-structure and open-ended 
interviews, which created by Glaser and Strauss in 1967. This analysis method in total 
consists of 14 steps (see figure).  
 
However, the limitations of interviews are not ignored as well. Kerlinger (1986) states 
that interview as typical methodology of collecting qualitative research is possible to 
make inappropriately explanation. Although interview focuses directly on the 
objective of research, the outcomes may response bias. Furthermore, sometimes the 
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answer could be reflexivity which means the interviewee gives what the interviewer 
wants to hear Yin (2009). 
 
3.3 Case study 
 
Case study is another approach adopted to investigate the current level of inventory 
management in hospital supply chain in China. Cohen and Manion (1995) defined the 
case study could observes the individual characteristics and the purpose of such 
observations is in-depth investigation and analysis multifarious phenomena. Yin 
(1984) asserts that case studies are appropriate for the target researching current 
events and single-case study is appropriate for the research exploring a formerly 
un-researched project. Considering with pharmacy trusteeship just began in 2011, 
moreover, few of collaborative inventories management in hospital pharmacy was 
presented before, thus single-case study is selected in this dissertation.  
 
7KHLQIRUPDWLRQFROOHFWHGIURPLQWHUYLHZUHSUHVHQWVSHRSOH¶VRSLQLRQVGHSHQGLQJRQ
different experiences and is more general level. The case study could reflect more 
penetrating questions and capture the richness of organizational behaviour and more 
convincing (Goble GG 1994). On the other hand, Yin (2003) refers that case study as 
an empirical inquiry that probes a contemporary phenomenon within daily life, 
especially when there are not clear evidences between phenomenon and context. In 
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this way, the case study of this dissertation give clear evidence to previous literature 
review, and fulfil the gaps and give answers to the research questions. 
 
Combining with the attitudes of supply chain contributors, the case study is more 
comprehensive and penetrating; because the object of this case is selected from above 
interviews to deep research. During the previous interviews, the author discovers this 
distribution company is trusteeing pharmacy of one large-scale public hospital in 
Beijing. However, due to trade secrets, the name of company cannot be disclosed. 
Although the case study enterprise is singular in this dissertation, the study involves 
three echelons in the pharmaceutical supply chain from manufacturer, distributor to 
hospital. Due to most of pharmacy inventory managed by hospital itself, there are 
mere a few pharmacies are trusteed by distributors in current China. Thus, author 
chose this relatively largely distribution enterprise and its managed pharmacy as 
research objects. The research targets finding out the specific issues in practical of 
current pharmacy inventory management between manufacturer, distributor and 
hospital and try to optimal solution of the problems.  
 
To be more practical, the solution would be evaluated by different companies and 
collecting more feedback. Thus, the outcome of the solution of this case would be sent 
to previous interviewed companies and hospitals. Considering the barriers of 
implementation, the result need be modify to more suitable and forward to implement 
into China pharmaceutical supply chain in the future.  
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However, there is not without disadvantages or limitations of case study. Above of all, 
according to statistics, until 2010, there were approximately 13,400 distributors 
including foreign invested and local companies in China. Besides, most of all are 
small medium enterprises. In additional, different provinces have different policies 
which probably effect the situation to distribuWRU 7KHUHIRUH MXVW RQO\ RQH FDVH¶V
analysis may not very generalization. However, this research like a miniature 
pharmaceutical industry still could reflect the current status of pharmaceutical supply 
chain, especially the echelons of distributor and hospital.  
 
3.3.1 Data collection 
The data collection is also the important work for research. The kinds of methods to 
collect are decided by strategy of research. There are several methodologies of data 
collection for case study, which are survey, observations, interview, etc. In this 
dissertation these techniques could be divided into two categories; primary and 
secondary data.  
 
3.3.1.1 Primary data 
In this dissertation, in-deep interviews and internal collection could be the main 
source of primary data. The reason why choose interviews is that mentioned before, it 
is the most efficient way of case study. The interviews were arranged with operation 
manager and logistics manager with semi-structure. Semi-structure allows the 
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interviewee could prepare some quantitative data like inventory cost. Additionally, 
some important qualitative questions would be answered more comprehensive if the 
interviewee knew the topics in advance. From interviews, the operation and 
management structure within the organization and external of manufacturer and 
pharmacy in hospital could be known, as well as the purchase and delivery of order 
management. There are qualitative and quantitative data among them. In terms of the 
quantitative data, it includes the product return rate. The historical statistics were 
offered by the interviewee, which reflected the capacity of current inventory 
management and was very valuable for this research.  
 
3.3.1.2 Secondary data 
In order to support interview, secondary data need be collected as well. For example, 
before interviews, the basic information of the company should be known, such as the 
scale of the business. This sort of data could be found from the website or annual 
report of the enterprise. Moreover, it is necessary the collection of the relevant 
knowledge of the objective for this case study. It includes books, journal or report.  
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3.3.2 Method of analysis  
3.3.2.1 Analysis process 
 
 
Source: Based on Wolcott (1994) 
Figure 3.1 Qualitative data analysis method 
 
Wolcott (1994) proposed an approach of data analysis of case study, which could be 
divided into three steps shown in Figure 3.1.  
 
3.3.2.2 Data flow diagram 
 
With regard to analysis tool, there are many business process modeling techniques 
shown on the Aguilar-6DYHQ¶V UHYLHZ LQ  VXFK DV FKDUW IORZ UROH DFWLYLW\
diagrams (RAD). However, the data flow diagram (DFD) was adopted by this 
dissertation. Compared with other techniques, the data flow diagram is for structure 
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analysis and easy to understand. In addition, according Aguilar-Saven (2004) DFD is 
as the name said which displays the flow of data or information from one place to 
another. It also describes the link processes between different external entity and the 
processes relate to the users and outside world.  
 
The reason why this dissertation selected this approach is that the case study focus the 
pharmacy collaborative inventory management thought analysis the relationship 
between those three parts (manufacturer, distributor and hospital) and their 
information flow exchange. DFD could introduce the data concerning the performer. 
Moreover, DFD only shows the information flow, which is very convenient for 
research to develop and reader to understand. In this research, the Data Flow Diagram 
(DFD) technique is applied to describe the current and improved process of inventory 
management between the three supply chain contributors. The draw of the DFD was 
based on the flow chart of order replenishment process and the interviews from the 
distribution company.  
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There are four main components need used to show the diagram, which are Data 
stores, Date Flows, Processes and External Entities (see Figure **).  
 
Source: Gane and Sarson (1977) 
Figure 3.2 four main components of DFD 
 
The Date stores are as a file or database responsible for storage of information. The 
external entity like a terminal sends out and accepts data within the organization by 
achieving the process which receives input data and yields outputs. The process is as a 
link between external entity and data stores. The arrow guides the direction of 
information flow and generally be named with the data. In addition, the data flow 
lines link all activities within the system including sources, process, data store and 
external entity.  
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3.4 Conclusion  
From this research, the attitudes of achieving collective pharmacy inventory 
management and the drivers and barriers were analysed by interviews from different 
aspects of pharmaceutical supply chain. Additionally, the main problems existing in 
current pharmacy inventory management were explored by in-deep case study. 
Having identified the issues, a potential solution was then proposed by using data 
flow diagram drawing an improved state of collective-managed inventory.  
 
However, expect that the method limitations were mentioned before, there are still 
some improvement could be achieved. Above of all, the situation of pharmaceutical 
supply chain is very complex in terms of policy, profit distribution, area control. Mere 
11 interviews and one case study must not be covered over. However, the time of 
research is limited with 3 months. The research strategies of this study may be the 
better approach to execute. With regard to date collection, the sources are from China 
companies, thus, it is necessary to translate all the interviews from Mandarin to 
English. To some extent, the differences culture between eastern and western may 
affect the understanding and interpretation of the results. 
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Chapter 4 
Data 
collection and 
analysis  
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4.1 Introduction  
This chapter mainly illustrates the data collected from interviews and case study, and 
with the in-depth analysis. There are 11 interviewees involved into the research. The 
issues they facing in current inventory management will be presented as well as the 
attitudes to implementing collaborative inventory management (CMI). Meanwhile, 
the divers and barriers of implementing CIM in China are the most important part of 
interviews. In terms of the case study, the company is selected from the interviews. 
Combining with the specific questions existing in the inventory management, the 
suggestions for improvement would be given in Chapter 5. 
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4.2 Interviews  
4.2.1 Manufacture perspective  
Three manufactures took participant in the interview which involved Harbin 
Pharmaceutical Group Factory, Astellas China Pharmaceutical Ltd. and Pfizer China 
Pharmaceutical Ltd. The background comparison is shown as Table 4.1. 
 
Harbin pharmaceutical Factory is one of branch factory of Harbin pharmaceutical 
Group. It is a large national pharmaceutical company and one of the 500 large 
industrial enterprises in China. It is famous for antibiotic production. The company 
runs with Quality first, the pursuit of human health as main goals. At present, there 
has been 8,000 staff with 2,000 technical staff.  
 
&RPSDUHGZLWK+DUELQIDFWRU\3IL]HUGHYHORSHGPRUHZLGHO\LWLVWKHZRUOG¶VODUJHVW
pharmaceutical company with its headquarters in New York. In 1980s, it entered into 
Chinese market. By far, the business is across over 200 cities with nearly 10,000 staff, 
and has been built 8 factories in South-east of China. The production line includes 
chemical drugs, bio-pharmaceuticals, vaccines, health drugs, etc. The top manager 
said that the goals of Pfizer in China are satisfying customer demand and keeping 
focus on their satisfaction.  
 
In terms of Astellas, it is a young enterprise, which has been reorganization since 
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2005. However, it grows rapidly being a second large prescription drug 
pharmaceutical group in Japanese with leading six area of immunosuppressive of 
organ transplantation, urinary tract, infectious diseases, CNS / pain, diabetes, and 
tumour. In 2007, it access to China pharmaceutical market with providing innovation 
and reliable service and making contribution for human health.  
 
Name of 
company 
Attribut
e 
Leading domain Core goals 
Harbin Factory 
China 
CHN Antibiotic production 
Quality first and 
care human health 
Pfizer China 
Ltd. 
US 
Drug of urinary &reproductive 
system and endocrine system, etc. 
Customer 
satisfaction 
Astellas China 
Ltd. 
JAP Drug of diabetes, and tumour, etc. 
Innovation and 
reliable service 
          Table 4.1  the main characteristics of three pharmaceutical companies  
 
From the literature review, it could be found that information exchange and sharing is 
the most important requirement for achieving collective inventory management. 
Therefore, the questions of interview mainly focus on information technology 
communication. When asked whether have information sharing with downstream 
partners, fortunately, the answers from all the interviewees were yes. However, it was 
just achieving between partly distributors. On one hand due to the different level of 
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development about hardware equipment, some distributors could offer online 
checking, such as sales, inventory data, time, batch number, the name of end 
customers. While little offer synchronized data checking for manufacturers. With 
regard to another protection policy in China, foreign pharmaceutical manufacturer in 
China are not permitted approaching medicine directly to hospital. It must contract 
with large-national distribution company which as sale agent, as well as taking 
participant in medicine bidding in China. Therefore, for Pfizer and Astellas the 
documentation of bidding are issued and submitted through the distributor that 
contracted. However, this kind of information sharing mere is by email. On the other 
hand, the reason that blocks information sharing is application of different software. 
As a consequence, the transmission of information are lagging, uncertain and unstable 
from distribution companies to manufacturers.  
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       Table 4.2 attitudes for implementation CIM from manufacturers 
  
However, when asked the attitude for implementation of collaborative inventory 
management of hospital pharmacy, the three manufacturers became different. The 
Support Un-support 
Harbin Pharm. Factory & Pfizer 
China 
Astellas China Pharm. Ltd. 
Drivers: 
1. Capture market information timely  
2. Promote product innovation  
3. Easy to supervision and management 
4. Uniform data management  
5. Reduce energy loss 
6. Reduce inventory and logistic cost 
7. Increase stock turnover 
8. Increase rate of funds utilization  
Reasons: 
Unnecessary for current situation in 
China. 
It is general that keeping a little more 
inventory for demand increase. 
By far, there is few problem about 
inventory management as long as 
inventory period at 0.5-1.5 month. 
 
Barriers: 
1. Loss competitiveness once 
information be opened 
2. The reliability of hardware equipment  
3. Large amount of investment  
4. Allocation of benefits 
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Table 4.2 shows the detailed of the diffidences. The operation manager of Harbin and 
Pfizer tend to support the implementation of collaborative inventory management. 
Because they both thought it allows manufacturer more involved in market and 
grasping the market dynamics. It is possible making production and resource planning 
timely. Especially for Pfizer as drug import, it is important to arrange the quantity and 
category, hence to reduce energy loss, inventory and logistics cost. Moreover, the 
systems must be uniformed with supply chain collaboration, it makes easy to monitor 
inventory level and make collaborative decisions with distributors as well as 
increasing stock turnover and rate of funds utilization. 
 
Although the young Astellas agreed with the point that collaborative management 
promotes product innovation, the company still not support inventory collaborative 
management. The operation manager thought it is unnecessary for current situation of 
China. The sales of representatives could be the link between manufacturer and 
hospital for promoting drug for doctor, gain some feedback of the drug use, as well. In 
terms of inventory, they hope to keep a little more stocks for urgency and rise sales as 
long as controlling the inventory coefficient between 0.5 and 1.5. In addition, there 
are not no barriers worried of implementing collaborative inventory management. 
From the aspects of Harbin, huge amount of investment needed for redesign and 
reform the infrastructures and systems. Furthermore, it factor of policy could not be 
neglected as well. Without government supports, it is hard to achieve successfully. On 
the Pfizer hand, it worried about losing competitiveness once sharing important 
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information with more partners. Moreover, how to allocation benefits once managed 
collaboratively pharmacy inventory still an uncertain problem.  
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4.2.2 Distributor perspective  
Table 4.3 Current status of distribution companies 
 
The interviewee distribution companies are Sinopharm, Shanghai pharmaceutical 
        
Compared 
 Name      
Items     
of company 
Rank  
Of   
Scale  
National  
network  
Provide  
3PL   
Logistic 
system   
Information    
Sharing     
Attitude 
of JIM   
Sinopharm   1   ¥              ¥       
WMS   
TPL etc.  
Partly upstream 
and downstream 
Positive   
SHP   2             ¥           
WMS 
etc.    
Partly upstream 
and downstream 
Positive   
Jointown    4   ¥      ¥         
LMIS 6.0  
WCS    
TMS etc.  
E-business Positive   
KY      21             ¥       
iWMS 
etc.    
Partly upstream 
and downstream 
Neutral   
Beijing 
Jewim   
<100                  
WMS   
DPR EDI  
RF etc.   
A few 3PL  Negative  
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holding Co.Ltd. (SHP), Jointown, KY, and Beijing Jewim Pharmaceutical Co.Ltd., 
respectively. Sinopharm and SHP are two large-scale State holding enterprises. They 
are two monopolies in China pharmaceutical distribution industry. Sinopharm owns 
the largest national distribution network with 25 distribution centres country-wide and 
covering all first class hospital and 95 per cent second class hospital in Beijing. The 
company has provided the third party logistics services since 2002. By far, it has 
provided service for Bayer, GlaxoSmithKline, Beijing disease control and prevention 
centre, etc. Compared with these two state-holding companies, Jointown is a young 
private distribution company with focus on developing their logistic service and 
E-business. It has wined 4200 upstream and 64000 business partners. Moreover, the 
development of E-business has achieved the information sharing between customers 
and allowed it being the third of China in mere five years. With regard to KY, it is a 
Beijing local distribution company. Due to continuously expanding market, it has 
contracted with 301 hospital pharmacy for supplying 80 per cent of medicine. It 
would be analysed detailed as a case in section 4.3. The SME (Small and medium-size 
enterprises) --- Jewim also was included in this interview. The scale of company is a 
key factor for the attitudes of implementing collaborative inventory management.  
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4.2.2.1Main issues 
Positive Neutral Negative 
Sinopharm ; SHP ; 
Jointown 
KY Jewim 
Key for CIM: Policies Key for CIM: Guanxi Key for CIM: Trust 
Main issues: 
1. Imbalance inventory  
2. High inventory cost  
Drivers:  
1. Enhance and increase the benefits of distribution company  
2. reduce bullwhip effect 
3. Increase stock and capital turnover rate 
4. Achieve overall planning and decrease inventory and logistics cost 
5. Risk-sharing with upstream and downstream partner 
Barriers: 
1. Low level of information technology communication and diversity of system  
2. Unwilling to share information, especially hospital 
3. Low integration of supply chain  
4. Uncertainty of risk-taking 
5. No standard process (drug code and logistics) 
6. Territorial restrictions 
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Table 4.4 attitudes for implementation CIM from distributor 
 
Compared with manufacture, there are more thorny issues facing on distribution 
companies. In addition, the barriers are not only about information communication, 
more factors from hospital and government, as well.  
 
From the interview, two urgent issues were found in terms of current inventory 
management. First of all, is imbalance inventory that reflected in two aspects. One 
aspect is overstock which caused by enlarged demand. The logistic manager from 
Sinopharm explained that it is general for distribution companies, because the supply 
chain is excessively long so that magnify the bullwhip effect. In addition, the orders 
of hospital are forecasted independently by pharmacist with less supply chain 
knowledge. Thus, the forecast itself may inaccurate. Almost all drug suppliers worried 
about whether their inventories could fulfil the demand. In order to avoid that, 
generally they would hold more inventories. As a result, for the suppliers at which top 
of supply chain, they have more overstock than others. Considering with the short life 
time of drug, it would bring high risk to distribution company. It is evidenced by 
Jewim that their average inventory cycle time is 59 days. It means the product held in 
warehouse nearly 3 months. Consequently, it creased much unnecessary cost, such as 
holding cost, premium, etc. Another aspect is stock out which caused by pressures of 
capital turnover. From the interview, Sinopharm and SHP indicated that one of 
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important driver encouraging them to support implementation of collaborative 
inventory management is pressures of capital turnover. Take SHP for example, the 
manufacturers generally requires the time of payment for SHP within 30-45 days, 
while the payment period of downstream hospitals for SHP is about 60 days. From 
this perspective, it can be seen that the role of pharmaceutical distribution companies 
LQIDFWSOD\HGDVDµ/HQGHU¶ 
 
 
Source: based on SHP interview 
          Figure 4.1 Account payable turnover period of pharmaceutical industry 
 
Therefore, once hospitals delay the payment time, moreover the company without 
enough capital for next purchase, it is very risky for stock out. However, it is because 
bulk ordering. If implementing collaborative inventory management of pharmacy, the 
demand controlled easily by suppliers, hence, narrowing the quality of order. 
Additionally, it accelerates the capital turnover rate and more conducive to 
development of SMEs.  
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The second issue are high inventory and logistic cost. .<¶VPDQDJHUVDLGWKDWWKHFRVW
of inventory and logistic expenditure approximately taking account for 65 per cent of 
total cost. There are two reasons, one caused by the characteristics of drug, such as, 
hygroscopic, perishable. Thus, the requirements of storage and transportation are 
relatively high. The other factor is economics of scale, small companies has no ability 
for establishment of distribution and logistics centre across districts. That is why, 
Jewim still not develops their own logistics team. According to calculation of the 
logistic budget for Jewim would exceed one third of the scale of sales. However, it is 
tolerable for Sinopharm, SHP and Jointown these large-scale companies which have 
abundant capital and sale market. Nevertheless, the businesses with strength are 
generally unwilling rent the facilities to SMEs, or even not cooperate with them. 
Hence, the development of distribution industry is unbalance because of less parallel 
collaboration. As a result, it is hard for SMEs to survival under the fierce competitive 
market. The private company Jointown suggested that it is better for SMEs 
concentrate on explore the core business and outsource the logistics part in order to 
shrink unnecessary cost. 
 
4.2.2.2 Barriers 
 
In terms of the barriers, the general problem that blocked the development of all 
distribution companies is information exchange and sharing, which is the same 
question as manufacturers. However, the reasons caused the problem are a bit 
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different, it not only diversity of software but also about the traditional thought. For 
upstream, for example, Beijing Jewim, do not have online information checking 
system connecting with suppliers. It was told that different manufacture has different 
system, hard to uniform and it would be costly. For downstream, hospitals insist on 
information privatization. Historically, the hospital as the biggest customer dominates 
the market and control the power of management and sale in China. Once open 
information, it certainly loses the dominated position. Therefore, hospitals unwilling 
to share information with any other supply chain participants. From another aspect the 
distributor itself, Sinopharm and SHP expressed that they hope get more information 
from both suppliers and customers, but unwilling to share more sales strategies and 
sales data with others in order to guarantee the leadership of the market. Especially 
the private company Jointown, it has to admit that its powerful logistic network, but 
not provide basic information checking. A reason from one manufacturer, it is 
suspected that Joint purchase from the province where low factory price and sells to 
another district with higher retail price. It is not allowed in China generally. However, 
in order to gain more profits, many companies have tried it. Therefore, it is unable to 
offer information online checking.  
 
Secondly, the barriers are from standard of industry. This is a limitation to the 
development of the industry. It has been a barrier for nearly 20 years in drug supply 
chain, from manager Xiao of Sinopharm. There is no uniform code applied in the 
whole supply chain. Current only basic drug which about 300 species do has uniform 
Dissertation of logistics and supply chain management 
80 
 
code. For others, there is one coding system for manufacture, and other one for 
circulation and even different between different company. Therefore, it brought 
difficulties for drug monitoring and tracing, furthermore having negative effects on 
information exchange of enterprises between each other and the development of drug 
logistics.  
 
The final barrier which strongly raised by the SMEs Beijing Jewim, it is territorial 
restrictions in China. It is extremely strict for local enterprise to establish warehouse 
cross districts. For example, Jewim is a company of Beijing, it is not permitted to 
establish warehouse in Shanghai.  
 
4.2.2.3 Attitudes 
 
With regard to the attitudes, it is not exactly same between different interviewees for 
implementing collaborative inventory management. Sinopharm and SHP presented 
support, because it could weaken the domination of hospital and increasing the 
control of distribution company. Moreover, it reduce the cost of imbalance inventory 
and they relief slightly from pressures of capital. SHP emphasised that inventory 
control would be effectively improved through implementation. Furthermore, the risk 
and cost are also shared by upstream and downstream partners of supply chain, under 
the current institutions and systems. When asked the key factor for successful 
implementation, policy is considered by the top three companies (Sinopharm, SHP 
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and Jointown). They thought it not be success without the government support in 
China. Although the CIM reduce bullwhip effect, increase the benefits of distribution 
company theoretically, there are many uncertainties, whether the implementation 
successes still need the examination of practices, the viewpoint from KY. However, 
KY referred to Guanxi the Chinese unique culture also is the essential for 
collaboration. On the contrary, Jewim has negative attitude to CIM, because the 
requirement and investment are too high to bear, it is less suitable for SMEs.  
 
4.2.3 Hospital perspective  
7ZRKRVSLWDOVLQYROYHGLQWKHLQWHUYLHZ3HNLQJ8QLYHUVLW\SHRSOH¶VKRVSLWDODQG
hospital). They are both first-class public hospital of Beijing. There are two reasons 
why choose them. Firstly, Beijing is the capital of China and the medical resource and 
the scale of hospital are the best and biggest in the country. In the meanwhile, 
thousands of categories of drug are managed by pharmacy.  
 
In general, it would be thought that hospital is an excessive profits organization in 
China. However, from the interview, only to find that Chinese hospitals especially 
first-class hospitals are operating loss which result of more concerning about health 
care, the level of research, while ignoring the operations. In terms of drug purchase 
process, it is managed confusingly. Contact supplier, product receiving and delivery of 
invoices, each key functions of the procurement chain cannot be separated. Moreover 
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there is no approval before purchasing, on written record, so that cannot check 
whether the quantity and drug regulations exactly same as procurement order after the 
product arrived. The other question is inventory management not standardized. HIS 
(hospital information system) has defective which affect the record of inventory level. 
Moreover, it is independent between hospital information system and financial 
settlement system. Consequently, the collection and statistics of data is lagged and the 
accuracy of data is seriously affected.  
 
Both hospitals indicated that they have already recognised the issue which is hospital 
QRWJRRGDWRSHUDWLRQ0RUHRYHUSURIHVVRU:DQJVDLGWKDW3HNLQJ8QLYHUVLW\SHRSOH¶V
hospital has ready outsource partly non-core business, such as scavenging and funeral 
service, but pharmacy still managed by themselves, because the drug management is 
one of biggest resource of profits for hospital. Although the management of drug 
inventory is not satisfying, there is hardly any stock out due to one category of drug 
having two or three suppliers. However, the overstock frequently happens. It could be 
improved by internal information construction and hospital resource planning. While, 
301 hospital supports the pharmacy trusteeship and has contracted with KY for 
managing 80 per cent of drug in 2011. The detail analysis is shown in section 4.3. 
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4.2.4 Government perspective 
The interviewee is one of officer from Beijing SFDA (Safe Food and Drug 
administration). The primary question that most concerned is whether the government 
VXSSRUWWKHFROODERUDWLRQPDQDJHPHQWRIKRVSLWDOLQYHQWRU\)URPDERYHFRPSDQLHV¶
interview, it is found that the decisive factor for company is government policy. 
Without the support of government, all theories cannot be achieved.  
 
The officer specified the most direct and important policies impact on the 
pharmaceutical distribution industry in contemporary China including: basic drug 
management, drug bidding management, drug price management, GSP (Good Supply 
Practice) regulation and healthcare insurance, etc. However, in the long term, the most 
far-reaching policy is the reform of public hospitals. From 1985, the reform of 
healthcare industry started until now has entered the third stage. The third stage focus 
on division of medical treatment and drug sale. In addition, it has been proposed about 
establishment of pharmacy trusteeship pilot among public hospital since 2011. 
However, currently there have not detail processes and regulations. The practice need 
to depend on the status of pilot hospital.  
 
Figure 4.2 The policies impact on pharmaceutical distribution companies 
Dissertation of logistics and supply chain management 
84 
 
4.2.5 Discussion  
Regarding implementation of collaborative inventory management, the attitudes vary 
from different participants. However, in general, it accepted by manufacture and 
distribution companies and gains the guide of government. However, the hospital still 
hesitate their position.  
 
From the aspect of pharmaceutical manufacturer, especially the foreign companies 
(Pfizer and Astellas) security of the information is the most concerned problem. It 
depends on the goals of the company. For example, Astellas is focus on product 
innovation, which means having risk of disclosure business secret once open 
information with partner. One more reason same as Pfizer is worried about the 
competitive would fiercer. While the most concerned problem of the Chinese local 
company is huge investment. There is less confidence for changing information 
system and worries for reliability of software. In the meanwhile, it reflects the 
traditional concept of supply chain still controls the Chinese company.   
 
However, with the demand increasing, these companies all have recognised the 
importance of information sharing. Furthermore, there are many drivers attracted 
them, such as increase stock turnover, reduce inventory and logistics cost and 
planning reasonable production. The most important reason is accurate and timely 
seizeing market. Therefore, most manufacturers are willing to make changes 
initiatively.  
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Compared with manufacture, the biggest barrier is the same which still information 
communication. However, it is caused by more of downstream factors which are 
KRVSLWDO DQG JRYHUQPHQW¶V DWWLWXGHV $OWKRXJK WKH KRVSLWDO KDV UHFRJQLVHG WKH
operation loss, they are still unenthusiastic to the collaborative inventory management 
of pharmacy. Because it has been a long-established for sale drug by hospital in China 
and never changed. The conventional thought is still deep-rooted. However, division 
of hospital and pharmaceutical has been raised by current China government. Actually, 
this proposition mainly for solve the problem of high drug price. From aspect of 
supply chain management, it can be seen that there are huge opportunities for 
intermediate links of supply chain---distribution company. Due to enhance the 
domination of market, reduce bullwhip effect and inventory, and increase stock and 
capital turnover rate, all the distributor desire the reform of hospital and implementing 
collaborative inventory management in pharmacy. Yet, some large-scale company are 
more positive while, the SMEs have more pressures to accept this reform.  
 
Apart from this, another barrier is high cost of logistic which obviously in small and 
medium enterprises. Although there are many drivers supporting collaborative 
inventory management, it also put forward higher requirements for distributors, such 
as faster and more accurate delivery. It is a challenge for the SMEs which have no 
matching logistic capacity for drug supply. Therefore, the Beijing Jewim has a 
negative attitude to collaborative inventory management. On the contrary, the large 
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economic scale companies (Sinopharm, SHP and Jointwon) very support supply chain 
collaboration even if the worries about the risk of disclosure of trade secrets. Because 
collaborative inventory management not only control effectively inventory level, but 
also make the capital risk-sharing with upstream and downstream of supply chain. 
Therefore, no matter government or manufacture and distribution company, they 
generally support the implementation of collaborative inventory management. 
However, there are still worries. Only the practice could test the theory. In the next 
content, the case of KY is detail analysed.  
 
4.3 Case study 
4.3.1 Background  
'XHWRWUDGHVHFUHWWKHQDPHRIFRPSDQ\KDVWRRQO\EHUHSODFHGRIµ.<¶LQEHORZ  
KY is a large-scale comprehensive enterprise, specializing in direct hospital sales, 
cross-regional distribution, vaccines sales, medical devices sales and retail business. 
In recent years, KY has gradually grown to be a pharmaceutical industry chain service 
provider offering customization, quality and integration services. Advanced 
information technology in operation attract many companies collaborate with it. The 
long-term partnership has been established with over 700 well-known pharmaceutical 
manufacturers both in China and aboard, which including Merck, MSD, Wyeth, Pfizer, 
GSK, Baxter, Fresenius and Novartis, etc. Win-win has been a core value of KY for 
many years. In addition, KY committed to continuously improve efficiency of 
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products circulation with achieving the goals of protecting human life and health.  
 
On the other hand, KY is continuously developing their third party logistics. By far, 
there has been an independent bonded warehouse, two GSP standard warehouses, two 
separated cold warehouses, comprehensive services of package, transportation and 
inspection, etc. It also provides delivery service in Beijing 24 hours one day and 5 
days a week with promise of half-day for reaching in the client and 2 days for the 
client outside Beijing. Moreover, the good cooperation relationships are with Beijing 
custom, SFDA (Safe Food and Drug Administration) and CIQ (Quarantine Bureau), 
etc.    
 
KY explores business actively with improving self-enterprise construction of logistics, 
information technology and internal supply chain structure integrating. Currently, it 
has already contracted with Beijing 301 hospital about pharmacy trusteeship. This 
was first large-scale hospital in Beijing signed with distributor for supply of 80 per 
cent drugs. KY managed as the third party, sharing responsibility for partly social 
functions. Thus, the cooperative relationship will be closer than before. However, it is 
a giant challenge for KY. Beijing 301 hospital is a large and comprehensive hospital 
with medical, healthcare, teaching and research. There are approximately 3000 
categories of drug and 80 per cent means about 2400 categories for KY. However, the 
old processes of replenishment still not be changed.  
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KY is effort to develop the customized information management system for achieving 
integration and exchange of information and sharing of sources with upstream and 
downstream partners. However, the most urgent issue is the change of supply model 
result in achieving collective supply chain management as soon as possible.      
 
The old model of pharmacy inventory management would be present in 4.3.2 with 
detail analysis as well as the main issues. 
 
4.3.2 Pharmacy Inventory management  
 
 
                      Figure 4.3  old process sketch                   
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Figure 4.4 the old model of drug replenishment in 301 hospital pharmacy 
 
Figure XX shows that the old model of inventory management in 301 hospital 
pharmacy with focus on the relationship between distributor (KY) and hospital 
pharmacy. This is a date flow diagram; consist of external entities, processes and data 
flow. It cannot be seen the physical flow from the figure. In the picture, the rounded 
rectangle means process of creating data, and the red rectangle is file or database of 
each process. The numbers shown on the each process and database represent the 
occurred orders. In term of the blue arrows clearly show the flow of information 
which are mainly from right to left. In this case, patients buy drugs from hospital 
SKDUPDF\ ZLWK GRFWRU¶V SUHVFULSWLRQV WKLV SURFHVV DFKLHYHG RQH GDWDEDVH RI VDOHV
history. Then the information of drug quantity transmits from pharmacy system to 
warehouse and checking the status of inventory with record. Unfortunately, these two 
valuable file would not open for the upstream partner (KY). Generally, each month an 
order is sent to KY through HIS system. The quantities of required drug are decided 
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by pharmacists according to their experience and skill and considered with historical 
statistic of inventory in hospital. In detail, each week the lists of drug purchase 
planning are submitted from sub-pharmacy of 301 such as outpatient pharmacy, 
emergency pharmacy, and examined and verified by pharmacy department once a 
month, finally purchasing order by purchase department. Once KY received the order, 
WKH RUGHU GHWDLO ZKLFK LQFOXGLQJ WKH FDWHJRU\ DQG TXDQWLW\ DUH WUDQVPLWWHG WR .<¶V
warehouse. The IWMS checks the whether the current stock available to 301. If the 
inventory could not fulfil the requirement of order, the operation manager will be 
noticed and decide how many stock need to order from manufacturers or suppliers. In 
this case, the delivery will be delayed. However, some drug could be replaced by 
other drug with general same functions. Under the permission of hospital, the 
distributor could do some exchange in order to satisfy the customer. If current 
inventory keep within the normal level, KY would calculate the economic order 
quantity and purchase from manufacture. Take Lotensin as an example, it is a kind of 
Antihypertensive drug, which be ordered from Novartis once or twice a month. After 
confirmation with customer about the order, the order detail will resend to warehouse, 
and then picking and packing with DPS (Data processing system). In the meanwhile, 
the delivery order is produced and sent to schedule delivery time with transportation. 
Normally, the products will be delivered with 24hrs. Once the products are shipped, 
the hospital would be noticed with the arrival time so that arranging products 
receiving. When the product arrived at the hospital, the staffs of pharmacy verify the 
category and quantity with delivery order. If there are correct, they sign on the 
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delivered note which then bring back by drivers. However, if the packaging is broken 
or the number and category of drug are not same as they ordered, they would contact 
KY as soon as possible by phone to rearrange next sanding, regarding the wrong drug 
are returned and brought back by drivers. Once received the delivered note, the 
inventory information would be changed by stock keepers. 
 
4.3.3 Product return rate 
From the interview and documentation of KY, the issue of high product return rate 
existing in current business between KY and 301 hospital.  
 
4.3.3.1 Backlog stock 
There are many return drugs to KY every year, which including the backlog stock 
during several months and damage product during transportation; it accounts for 4 per 
FHQW RI .<¶V JURVV VDOHV DOWRJHWKHU IRU  KRVSLWDO ,Q DGGition, the backlog drug 
would return to KY with purchase price. All the economic losses are responsible by 
KY totally. It is a big blow for an industry with already very little profit.  
 
In terms of backlog stock, it accounts for approximately 3% of all return products. 
The categories of drug are more than five thousand in 301 hospital. The wide range of 
category and a large amount of drug cause frequent errors in inventory accounting and 
management. The may slow down the information feedback of medicine inventory 
Dissertation of logistics and supply chain management 
92 
 
level. Furthermore, the forecasting of demand is predicted by doctor and pharmacist. 
Due to lack of professional knowledge of supply chain management, the forecasting 
of demand is always fluctuating and incorrect. In order to guarantee the enough drugs 
to supply in pharmacy, the quantity of order is frequently higher than normal level or 
plus or minus a certain percentage according to former order quantity without 
systematic hospital resources planning. Moreover, the warehouse staff neglect 
inventory checking regularly. As a consequence, many drugs could not be consumed 
as soon as possible. With time accumulation, these products turn to backlog stock. In 
addition, the backlog products are stored in the pharmacy warehouse as the castoff 
and without cares; most of them are damaged and expired. All backlog drugs are 
repurchasing from hospital once three months with the same price. In China, it is 
forbidden that sale expired medicine by reduce the price. Thus, KY has approximately 
0.6 million RMB loss from this dispose every year. For decreasing the uncertainty of 
demand, KY makes forecasting according the change of seasons and preparation in 
advance. Because the temperature changes obviously between four seasons, there are 
some common diseases and regular demand of drug. For example, the demand of cold 
cure increases largely in winter. Although it is a guide for predict in advance, it still 
cannot solve the fundamental problem. On the other hand, this kind of self-forecasting 
makes there are large inventory of useless drug and no drugs in urgency situation. It 
seriously affects the development of medical business. Moreover, it accounts for 
about 40-60 per cent of 301 hospital liquidity.  
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4.3.3.2 Logistic waste 
Another waste caused by logistics. Although the transports are running by KY itself, 
there is still 1 per cent loss caused during transportation. Because the amount of 
demand increased by 60 per cent, the requirement of transportation increasing as well. 
For example, vaccines are transported under relevant low temperature. In the case of 
mechanical stoppage of vehicles during delivery, it affects directly on the quality of 
vaccines. Another reason for logistics waste is traffic congestion. Beijing is famous 
for its traffic congestion. In order to relieve the pressures of transportation, there are 
limited vehicles by license number at each working day. Therefore, it has serious 
effect on schedule and availability of vehicles.  
 
These two questions directly reflect the barriers facing on KY are passive information 
sharing and uneconomic logistics.  
 
4.4 Conclusion  
From interviews and case study, the two biggest questions that existing in current 
inventory management are imbalance inventory and high inventory and transportation 
cost. The inventory problem is caused by inefficient information communication 
among in supply chain. While, the logistics cost reflect low logistic capacity. In order 
to solve this problems, almost participants have the positive attitudes to implementing 
inventory management, because there are many drivers such as enhance market 
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position, reduce inventory cost, etc. However, some worries of information security 
are existing. In addition, hospitals still have hesitate attitude for pharmacy trusteed by 
wholesaler/distributor. Although the government give the proposition of pharmacy 
trusteeship, there is still not detail guidance for how to execution. Therefore, the 
implementing of collaborative inventory management still relies on the negations with 
hospitals. Thus, KY and Jewim both indicate that key for implementing collaborative 
inventory management are building long term trust and developing Guanxi (individual 
relationship) in China.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Dissertation of logistics and supply chain management 
95 
 
 
 
Chapter 5 
Finding and 
discussion  
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5.1 Introduction 
This chapter shows the initial and final suggestions for KY by using collaborative 
inventory management. To be more practical, the final suggestions are modified 
following the feedback from previous interviewees with form of data flow diagram. In 
addition, combine with the outcome from interviews, the discussion of implementing 
collaborative inventory management in China is presented finally.  
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5.2 Suggestion for KY  
According the issues in case study and the review from literatures, the process of 
order replenishment was redesigned on the basis of collaborative inventory 
management. Furthermore, combined with the current limitation in practice between 
KY and 301 hospital, three suggestions has been proposed as below: establishing 
external warehouse, information sharing and logistics outsource. In terms of the 
improved parts, which have been already highlighted in the figure XX. 
 
 
Figure 5.1  KY improved sketch 
5.2.1 Establishing external warehouse  
From case study, the managed drug by KY only account for 80 per cent of the total 
GUXJ LQYHQWRU\ RI ¶V SKDUPDF\ 7KDW PHDQV WKHUH DUH VWLOO  SHU FHQW RI GUXJ
PDQDJHGE\KRVSLWDO LWVHOI7KXV LW LVGLIILFXOWIRU.<XQLILHGPDQDJHPHQW LQ¶V
warehouse. Besides that, it is less likely that 301 hospital outsources their warehouse 
to KY, because there might still are other items such as medical equipment. Therefore, 
establishing external warehouse exclusively for the hospital is an alternative method. 
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The location of the customized external warehouse must near the hospital, which 
avoids some traffic problem and allows faster to delivery. This external warehouse 
operated by KY itself, using a same data management system with the headquarter 
warehouse. Thus, it is better for inventory monitor and replenishment timely. 
Moreover, the barrier of sharing inventory information with hospital could be 
overcome. In other words, KY no longer has to worry about the forecasting delay or 
inaccurate from the hospital and whether the information communication system or 
software are compatible. For the current stage, the problem of software development 
for hospital inventory control has been skipped, meanwhile, obtaining the results 
which same as achieving inventory data sharing with hospital. 
 
5.2.2 Information sharing  
The second improvement is for information sharing. Stank et al. (2001) point that the 
change from standard business practice, especially from information exchange is the 
most important requirement for a successful collaboration. In addition, from the 
literature review Disney and Towell(2003) said that VIM could reduce the bullwhip 
effect which caused by demand change from downstream, while CPFR allows 
upstream and downstream sharing information (Danese, 2007). Therefore, one of 
most suggestion for KY is sharing the inventory data and sales histories of two 
warehouses both the external and headquarter with suppliers (manufacturers). Thus, 
manufacturers could control the production planning and make joint decision with 
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distributor (KY) as well as the up-to-date of sales data promotes the innovation of 
medicine . 
 
With regard to communication with hospital, due to the establishment of external 
warehouse, it no longer need forecast from pharmacist, meanwhile achieving 
real-time monitor. Thence, by far the problem is concerning with the acquiring of 
sales detail from hospital. Theoretically, it also becomes easier through external 
warehouse management. Only sales data sharing can be achieved replenishment 
timely. Moreover, KY has started the developing for the system which connects with 
financial system of the hospital. According to interview, one system has already been 
explored which succeeded for drug return, and named HIEP (see figure 5.2). 
 
5.2.3 Logistics outsourcing 
The final improvement, it highlighted in figure XX with blue line. Due to one of 
biggest barrier indicated in the interviews, which is high cost of self-running logistics. 
.<¶VPDQDJHUVDLGWKDWWKHFRVWRILQYHQWRU\DQGORJLVWLFH[SHQGLWXUHDSproximately 
taking account for 65 per cent of their total cost. In addition, Jointown also suggested 
that it is better for small and medium enterprise to outsource their non-value adding 
process to the third party logistics company. Quinn and Hilmer (1994) point that 
outsourcing has advantages of access to economic of scale, flexibility and makes the 
company focus on its core activity. Razzaque and Sheng (1988) indicate that 
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outsourcing regarded as a useful approach to lowering costs and gaining competitive 
advantage worldwide. According to statistics, the companies gain a 9 per cent costs 
saving and a 15 per cent increase in terms of quality and capacity through outsourcing 
(Elmuti et al., 1988). With the dramatically development of economy, the 
transportation and logistics has been the most popular sectors of outsourcing in a 
widespread diversity of industry (Transport Intelligence, 2004). Therefore, it is 
proposed that implementing outsourcing of logistics instead of self-running in order to 
effective control cost.  
 
5.2.4 Detail explanation  
 
Figure 5.2  KY Improved data flow diagram 
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A revised data flow diagram for the CIM solution can be seen in figure XX. With this 
new process, the three improved places were highlighted, two with red dotted boxes 
and one with blue box. At top of right hand side, it is the outsourcing to third party 
ORJLVWLFVVHUYLFH,QWKHPLGGOHRIWKHSLFWXUHLWLV¶VKRVSLWDOH[WHUQDOZDUHKRXVH
which established by KY strengthened with red dotted box, while its left is the 
improvement of information sharing with manufacturers, which surround in another 
red box. Regarding the order of the replenishment in the figure, should be from right 
to left, guided by the number in each box.  
 
Firstly, the sales data are transmitted from each sub pharmacy to both external and KY 
headquarter warehouses through the inventory monitoring system, as well as the 
manufactures, once the payment of patients finish. With the update of sales, the 
inventory level should be also fluctuation. If it low behind the safe inventory, the 
replenishment would be launched automatically and following by the picking and 
packaging. In the meantime, the delivery order is produced and sending to the 
logistics service provider to range vehicles, as well as notice sub pharmacy ready to 
receive products. The third party logistics company delivery the drug as well as the 
delivery note to sub pharmacies as soon as possible. After the pharmacy staff signed, 
the copy of the delivery note will return by driver. If there is some damage of package, 
the refused drugs will brought back with the driver, as well. At the same time, the 
return detail would back to external warehouse immediately through the system HIEP 
and achieving real-time inventory update. Due to a same inventory management 
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system both used in branch and headquarter warehouse of KY, all data are monitored 
E\.<7KHUHIRUHWKHUHSOHQLVKPHQWRI¶VH[WHUQDOZDUHKRXVHLVDXWRPDWLFDOO\DQG
promptly.  
 
As it was mentioned before, the sales data would be shared with manufacturers as 
ZHOOWKURXJKWKHLQYHQWRU\PRQLWRULQJV\VWHPRI¶VH[WHUQDOZDUHKRXVHZKLFKFDQ
be found in the red box at left hand side of figure 5.2. Meanwhile, the inventory data 
are also shared between KY and manufacturers. Collecting more information of 
inventory and sales, allows the manufacturers arrange production plan reasonable and 
make joint market forecasting with KY. As the example of Wal-Mart in the literature 
reviews, suppliers would offer a suggested order or forecast for Wal-Mart, a little 
modify after combining with the forecast of themselves. The method could be applied 
into China pharmaceutical supply chain.       
 
In theory, these three improvements achieve the effective information communication 
among the whole pharmaceutical supply chain. In addition, the non-value process 
could be cut off so that reduce the high cost of logistics as well as achieving high 
efficient distribution. However, there are still some problem when get feedback of this 
solution.  
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5.3 Feedback and improvement  
In order to make the solution more practical, first of all, the solution must be shown 
and explained to KY and 301 hospital. At the same time, it is given back to those 
interviewee companies. Although the solution was generally accepted by most 
companies, there were still some problems need to consider.  
 
The first and most important problem is exposed by KY, which is about the rental cost 
of external warehouse. The 301 hospital locates in Beijing, thus, the external 
warehouse should be established in Beijing, as well. However, the land price in 
Beijing is too expensive to undertake. However, the solution for short term and urgent 
is very effective.  
 
With regard to information sharing, almost all feedbacks support the improvement 
about inventory monitoring which not only through the distributor, but also 
collaborating with manufacture. However, it makes worries in terms of sharing sales 
data by real-time. From the aspect of manufacturers, to some extend degree there is 
risk of secret disclosure if the sales information of all types of drug are opened 
simultaneously. Because, there may be thousands of types of drug, the difficulty of 
management is larger than before. The security of data transmission might be affected 
by an increase in the number of drug. For example, some best-selling drug might be 
copy though steal information, result in unfair competitive. Especially for the 
company Astellas that depending on product innovation, there is high risk of 
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competitiveness loss once important information disclosure. From the aspect of 
distributors, there is the same worry as manufacturers. However, the loss of 
distribution channel is the focus of them.  
 
Figure 5.3 the final solution of KY  
 
Combined with the two worries form manufacturers and distributors referred in above 
section, the solution is improved again in order to be more practical. 
 
Firstly, the improvement for avoiding risk of sales data disclosure is change the form 
of exchange instead of cancel the sharing of sales data completely, because it is 
indeed valuable for manufacturer. Thus, an alternative solution could be attempted. 
The sales data could be disposed by distributor before sharing with each other. For 
example, the sales data could be collected by weekly with analysis and integration, 
and sending to the upstream partners.  
 
7KH VHFRQG VROXWLRQ PXVW EH DFKLHYHG XQGHU ¶V KRVSLWDO VXSSRUW ,I WKH KRVSLWDO
agrees to transfer the rest 20 per cent supervision right to KY, and outsourcing the 
warehouse of hospital to KY. That would be the best solution. However, it is needs 
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government support and making great effort by KY itself, to gain the trust and keep 
good relationship with the hospital. Moreover, it is a long term strategy.  
 
5.4 Discussion implementation of CIM in 
China 
Considering the results of interviews, the answers are discussed combined with the 
current status of China, thus, some suggestions would be given as well.  
 
5.4.1 Drivers 
5.4.1.1 Expanding market 
The most attractive driver for Chinese pharmaceutical to accept collaborative 
inventory management is expanding the market, no matter for manufacturers or 
distributors. It would change the current situation to profits squeeze for distributors. In 
addition, managing the inventory of hospital allows the operation of distributors more 
flexible and efficiency depending on their own interest as long as fulfilling the orders 
(Bhakoo,2012). Under the traditional model, the suppliers (manufacturers) were 
selected and decided by hospital itself. Compared with the situation before, the 
distributors are going to control more resources which are not only stocks of hospital, 
but also the suppliers. It means that distributor could make joint decision with hospital 
for supplier selection. Meanwhile, it would bring challenges, as well. For example, 
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GHYHORSLQJWKHVXSSOLHU¶VDVVHVVPHQWPHWKRGDQGWKHDELOLW\RIVDOHVGDWDDQDO\VLVDQG
many aspects need be improved in the future.  
 
In terms of the benefits for manufacturers, more up-to-data information are collected 
through information sharing and collaborative planning and forecasting with 
downstream partners, which promote their ability of innovation of product according 
to customeU¶V UHTXLUHPHQW (Kamalapurkar,2011). However, Stank et al. (2001) state 
that not all the information in the same level could be achieved from all the 
distribution channels. As the study of Bhakoo (2012), it is worth noting that a number 
of companies would not integrate the received data into their activities. 
 
5.4.1.2 Reduce cost 
Another dramatic driver is cost reduced in terms of manufacture, distributor and even 
hospital. From the literature review, it can be found that collaborative inventory 
management makes effective communication between upstream and downstream of 
supply chain, so that reducing the cost which caused by bullwhip effect. On one hand, 
due to inventory are lessened, the hospital has no more payments of labour salaries, 
and energy costs for running the warehouse. On the other hand, there are less worries 
about the product return which caused by backlog stocks in hospital, thus avoiding the 
unnecessary loss. Meanwhile, the inventory in the warehouse of distributor decreased, 
as well because of the flexible and high efficiency management, and the inventory 
cost would shrink without surprise. With regard to manufacturer, from a few 
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information exchanging to collaborative planning and forecasting, it makes possible 
for manufacture to arrange production reasonable, especially for the material import 
of foreign companies. Kamalapurkar (2011) say that it would be more costly at the 
beginning of the collaborative inventory management because of the establishment of 
infrastructures and information systems; however, more benefits would be acquired 
for long term collaboration.  
 
5.4.1.3 Sharing reward and risk 
As it been found from interview, a general idea of supporting collaborative inventory 
management is sharing reward and risk with partners. In fact, many distributors and 
manufacturers are willing to change initially, but who will undertake the risk and the 
expenditure for change is the most concerning question among all participants in 
supply chain. Currently, the pharmaceutical distributor in China has played a role of 
µOHQGHU¶ ,W PHDQV WKDW ODUJHVW ULVN IURP FDSLWDO WXUQRYHU LV HQGXUHG E\ GLVWULEXWRUV
Therefore, the implementation of collaborative management could accelerate the time 
of payment of hospital, thus the risk of stock-out could be dramatically minimized. In 
the meanwhile, the manufacturer is a beneficiary, because there is more investment 
from distributor for research and development (Danese,2006). Furthermore, through 
the contract collaboration could share risk when loss occurs, rather than pay it 
individually like present.  
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5.4.2 Barriers 
5.4.2.1 IT system diversity  
Most of people indicate that the low application of information technology is the basic 
reason (Andy and Mehmet 2010, Cantor 2006). However, in this research, another 
reason has been found which is caused by the diversity of the information system. 
According to the interview, although the biggest the barriers is the information 
sharing, the root causes is the multiple and mass information system. It is difficult to 
achieve information sharing smoothly because of this diversity. Singh also find that 
integration of information system is the key to develop supply chain collaboration.  
 
Among the interviewees, there are one hundred per cent applying rate of information 
system Moreover, almost all companies have their enterprise resource planning (ERP) 
system expect Beijing Jewim. However, different system developed by variety of 
developers. Moreover, the more differences are on warehouse inventory management 
(see figure 5.3). Furthermore, there are about 13,461 distributors, 4678 manufacturer 
and approximately 20,000 hospitals in China by the end of 2010 according to the 
statistics form SFDA. Therefore, it is more difficult to uniform the types of the system. 
However, the eight interviewed enterprises, most of them are large-scale companies, 
only Beijing Jewim is a SME without ERP system. It is evidence that the application 
of information communication technology has been not yet universal.  
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5.4.2.2 Conservative ideas 
In general, Chinese enterprises are reluctant to open their information, even if many 
large-scale companies, which decided by Chinese culture (Chow, Deng, and Ho, 
2000). Actually, it is more serious on state-owned organizations, in this research is 
hospital. Some advanced concepts, technologies, and management system have been 
locked in China, because of the unwilling to accept. The change of information would 
certainly bring some influences.  
 
There are many reasons for the reject. The first one is less confidence to the success. 
From the interview, the foreign companies represent that they worried about the 
security of the information sharing, while the state-owned manufacturer and small and 
medium enterprises suspect the trade-off of investment and pay back of software 
system development.  
 
5.4.2.3 Lack of government guidance   
Although the Chinese government has proposed the pharmacy trusteeship since 2011, 
the detail policies and regulations still have not published. In addition, the business of 
pharmacy inventory management depends on the negotiation between distributor and 
hospital themselves, under the current situation. Moreover, the current pharmacy 
trusteeship just enlarges the amount of supply not truly achieving collaborative 
inventory management. The most worried from distributor is the changes occur of the 
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direction of development and who should undertake the risk and loss once the reform 
fail. Therefore, the factor from government could not be ignored.  
 
5.4.3 Overcoming the barriers of CIM in Chain  
5.4.3.1 Supply chain integrating and reduce diversification  
The integration of supply chain has been the worldwide topic with significant debate 
and discussion. It is focus on develop partnership and effective information exchange 
and sharing with business partners (Power, 2005). From the literature review, in China, 
although the medical market has dramatically increased recent years, the 
pharmaceutical supply chain is long and the structure is complex, which will certainly 
impede the collaboration of supply chain and increase difficulty of information 
sharing. Therefore, the supply chain integration and narrow differences are the basic 
solution for accelerating collaborative inventory management.  
 
The so-called integration in China pharmaceutical is to make effort to develop 
large-scale enterprises according to the report of NEC. From the literature review 
there were over 13,400 distributors. This is a huge number than American where only 
has approximately 70 distributors. Hence, it is necessary to decrease the number of 
competitors in horizontal (Theodore et al., 2001). In details, the large-scale companies 
could joint together to be strategic partners understanding customer value and demand, 
making joint operation planning, so that promoting the product and service 
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capabilities. As a result of this strategic alliance, there is less space for small 
companies to survival.  
 
With regard to vertical, there were 4678 pharmaceutical manufacturers and more than 
20,000 hospitals by the end of 2010. The emphasis of integration for distributors is 
implementing performances evaluation for suppliers (manufactures) and building long 
term trust with downstream partners (hospitals) Ellram,1991; Macbeth and Ferguson, 
1994). Finally the number of suppliers could be minimized thought performances 
evaluation and the relationship with customer is more solid, so that building uniform 
information communication system and achieving collaborative inventory 
management.  
 
In addition, enterprise should also strengthen the information technology integration. 
According to the solution that raised by Nippon Electric Company in 2012, the 
integration information system should be applied within the company, and the data 
exchange system should be used between enterprises. Furthermore, the portal of the 
company should base on work platform system. Only enhance the internal integration 
can achieve the external uniform, thus, achieving information exchange and sharing 
smoothly among the supply chain partners.  
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5.4.3.2 Developing trust and Guanxi 
From the interview, KY and Jewim refer that the trust and Guanxi are two of most 
important factors for collaborative inventory management in China; these are the most 
effective ways to knock on the door of the hospital.  
 
First of all the transaction cost could be reduce base on the trust relationship in supply 
chain. (Brian et al., 2012) When the trust is high, it is easier and faster to make joint 
decisions by using the information that from each other. Moreover, it also help 
product design, activities management and added values creation through the freely 
and smoothly flow of product, services and ideas, etc (Das and Teng, 1988, 2002). 
While, when the trust at a low level, even if the alliance still exist the effectiveness 
would be to some extent blocked (Lewicki et.al., 1998; Kwon and Suh, 2004;). 
However, Brian et al. (2012) indicates that the trust is valuable for management 
purposes and helps to improve the performance of supply chain collaboration, but it is 
still hard to gain the related quantities data. Moreover, Daugherty et al. (2006) 
emphasizes that trust building is a long term project. Beijing Jewim as a small and 
medium enterprise has been committed to build good relationship with partner to win 
more opportunities.  
 
In China, there is an essential factor to build trust, which is Guanxi. Guanxi seems 
like an individual factor which has played a significant role on gaining trust and 
establishing collaborative relationship with buyer (Lee and Dawe, 2005 and Leuang et 
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al., 2005). Sometime, the personal Guanxi could decide whether it succeed or not for 
a project bidding. Therefore, the distributors could try to build good Guanxi with 
hospital, so that gain more orders about drug supply and gradually win the trust from 
hospital achieving pharmacy trusteeship, under the current situation in China. KY also 
points out that gaining the project of 301hospital pharmacy trusteeship is contribute to 
NHHSLQJORQJWHUPJRRGUHODWLRQVKLSZLWKJRYHUQPHQW¶VRUJDQL]DWLRQV  
 
However, Steidlmeier (1997) asserts that there would be a risk of bribery if over build 
the Guanxi though gift giving, winning and dining. Therefore, although the Guanxi is 
an important factor to successful collaboration, the enterprise still needs to enhance its 
internal service level firstly. Only after that can enterprise build high trust with 
partners.  
 
5.4.3.3 Developing third party logistics  
In China, many enterprises run the logistics by themselves, with low profits and high 
investment (Rahman and Wu, 2011). In addition, from the aspect of scale of economy, 
building a modern logistics centre cannot without fixed investment in equipment and 
the support of advanced technology, information system, automated warehouse and 
national distribution network, etc. However, it is no doubt a huge challenge for the 
small and medium enterprises. 3PL (third party logistic) could solve this problem. 
3PL (Third party logistic) means that the external logistic organization acts as the 
connection between company and client to provide logistic services. With the 
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increased market competitions and customer requirements, more and more companies 
outsource their logistic activities to third party logistic service providers in order to 
pay more attentions on their core activities (Vaidyanathan, 2005) and to achieve 
greater competitiveness (Quinn and Hilmer, 1994; Welson, 1996). Fleischmann and 
Daganzo (1988) 3PL point out that the transportation costs and performances are 
highly decided by distribution structure. The professional team of third party logistics 
could offer customized and high quality service (Rahman and Wu, 2011). Therefore, 
for the development of SMEs, the 3PL is a good choice.  
 
However, in China the development of pharmaceutical logistics is undergoing a 
hardship. The primary reason there is extremely high standard of entry this 
pharmaceutical third party logistics industry (Xu, 2011). Therefore, only a few 
large-scale commercial groups have their own distribution network, such as 
Sinopharm, SHP and Jointown in the interview. Hence, the development is very 
imbalance. However, on the other hand, it contributes to maintain market order and 
easy to supervision. Moreover, on one hand it must be merged in the competition for 
some small companies. On the other hand, it is a huge opportunity to enhance market 
for large-scale companies, so that accelerating the integration of Chinese 
pharmaceutical supply chain. 
 
In addition, there is another problem fettering the development of pharmaceutical 
logistics, which is less uniform standard in national wide. From the interview, it is 
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generally response that the barcode application is not standard in terms of one barcode 
with multi-purpose and different code size (Liu and Xing, 2011). Due to no uniform 
coding for all types of drug in Chain, some distributors developed their own barcode 
for logistics conveniently, as a result the drug is hard to be traced once leave factory. 
Moreover, it is have a serious effect on information sharing between upstream and 
downstream partners of supply chain, as well as the product return in healthcare 
industry (Brian et al., 2012). On the other side, the logistic standard is not also 
uniform, such as the pharmaceutical logistics containers, pharmaceutical packing box, 
and medicine storage tray. Therefore, only rapid developing third party logistics can 
accelerate the integration of pharmaceutical industry  
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5.5 Conclusion  
According to the interview, there are two main problems facing on Chinese 
wholesaler/distributor companies, which are imbalance inventory and high inventory 
cost. In addition, from the case, it could be found the relative high product return rate 
which cause by backlog stock and logistic waste. These problems full reflect the root 
problem which is inefficiency information communication with partners. In order to 
solve this problem, a detail and customized solution was come up for KY.  
 
By using the VMI and CPFR, there is a suggestion for KY. It proposes that building 
an external warehouse for 301 hospital and achieving the real-time sales information 
sharing with it. In the meanwhile, it suggest that KY should share the real-time sales 
information with suppliers (manufacturers) as well, and allows the inventory level 
monitoring by suppliers, so that suppliers and KY could make joint replenishment 
planning and forecasting. In addition, considering with the high logistics cost, the 
outsourcing transportation as another suggestion for KY to reduce the cost.  
 
In order to be more practical, the initial suggestions are sent to the interviewee 
companies. According the feedback, there are two point need to be considered in the 
future implementation. The first one is the rental of external warehouse, if the hospital 
agrees outsourcing their warehouse; this problem will be solved in the future. The 
other problem is the security of information sharing. Almost all companies worried 
about the risk of information disclosed, so that decreasing their competitiveness. 
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Therefore, the final modification is that the sales information is analysed and 
integrated by KY first, and then, send it to them with the form of report instead of 
sharing the real-time sales information directly.  
 
With regard to implementation, there are still many barriers under the current 
environment of China. From the literature review, many research reveal that it is 
because low level application of information technology. However, in this research, 
the result is slightly different. The reason that block information sharing among 
supply chain are diversity of the information system and the Conservative ideas of 
unwilling to change in China, as well as lack of guidance from government. 
Combining with the current status and culture of China, three suggestions are 
discussed in the final. They are reducing diversification, developing trust and Guanxi. 
Another barrier is high cost of self-running logistics from the case study. Therefore, 
developing third party logistics as a suggestion for China is discussed, as well.  
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6 Conclusion  
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6.1 Summary  
According to the literature review, it can be known, the supply chain collaboration is 
an increasing popular concept applying in many industries, such as manufacture and 
retail. In addition, there are many useful methods for achieving supply chain 
collaboration such as VIM (vendor-managed inventory), CPFR (Collaborative 
planning, forecasting and replenishment). They could enhance the relationship and 
information exchange and sharing between partners, and reduce the general bullwhip 
effect. However, as a particular industry, the development of collaborative inventory 
management is still immature compared with other industries.  
 
Moreover, the current status of China pharmaceutical supply chain has also been 
mentioned in literature review. The number of participants, especially 
ZKROHVDOHUGLVWULEXWRU LV KXJH FRPSDUHG ZLWK ZHVWHUQ FRXQWULHV¶ $OWKRXJK WKH
number is huge, lack of market integration which reflecting in two aspects: low 
market share for large-scale companies, a large number of scattered small companies 
with low margin profits. Many companies develop independently lack of 
collaboration with upstream and downstream partners. Moreover, the hospital 
dominates the pharmaceutical market and nearly 70 per cent drug selling in the 
hospital. However, due to lack of the knowledge of supply chain, less information 
sharing, the forecasting of demand is frequently inaccurate, which cause large number 
of backlog inventory in hospital. However, finally it is the wholesaler/distributors and 
some manufacturers that pay the bill of waste. As a result, it brings huge loss to 
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wholesale/distributors and manufacturers. Therefore, companies need to find specific 
strategies to manage their supply chains. In this dissertation, it focused on strategy 
collaborative inventory management; they are VMI (vendor-managed inventory) and 
CPFR (collaborative planning forecasting and replenishment). Because VMI could 
effective reduce the bullwhip effect and enhance the relationship between partners, 
while the CPFR enhance the centre position of wholesaler/distributor and allows all 
supply chain partners involved joint planning and forecasting.  
 
6.2 Outcomes 
According to the interview, the research question 1 (what are the current issues of 
hospital pharmacy inventory management in China?) has been answered. There are 
two main problems facing on Chinese wholesaler/distributor companies, which are 
imbalance inventory and high inventory and transportation cost.  
 
In addition, the problem existing in the case study is high product return rate, which 
cause by backlog stock and logistic waste. Combining with the issues from the 
interviews, these problems full reflect the root barriers of achieving collaborative 
inventory management. The two main barriers are inefficiency information 
communication and low logistics capacity in China. Therefore, the research question 
2 (what are the drivers and barriers to achieve collaborative inventory management in 
pharmaceutical supply chain?) has been finished as well.  
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Finally, the two main barriers divided into several points, such as IT system diversity, 
conservative ideas and lack of government guidance. Combining the Chinese capacity 
and culture, the solutions has been discussed at the end. They are integrating supply 
chain and reduce diversification, developing trust and Guanxi, and developing third 
party logistics. Therefore, the research question 3 (How to implementing collaborative 
inventory management in China in the future?) has been answered finally.  
 
6.3 limitations of this research 
In terms of limitations of this research, there are two aspects need to be pointed out. 
The first point is that for the case study there should be more quantitative data 
explored, such as three months inventory cost analysis. It should be more persuasive. 
However, due to relating to trade secret, KY has mere provided the replenishment 
process mapping and general proportion of relevant information, instead of offering 
specific number about sales and cost. The second limitation is that this research just 
involved 11 interviewees and one case study. The data is quite limited to show the 
whole status of whole pharmaceutical. However, it still reflects the main typical issues 
and barriers of implementing collaborative inventory management.  
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6.4 Recommendations on future researches 
Although this dissertation has indicated the main issues and barriers of implementing 
collaborative inventory management as well as the suggested solution. However, the 
effects need to be examined in future practices. In addition, whether the collaborative 
inventory management suits for SEMs or not need further research.  
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